Interaction	O
of	O
sickle	B-cell_type
erythrocytes	I-cell_type
with	O
endothelial	B-cell_type
cells	I-cell_type
in	O
the	O
presence	O
of	O
endothelial	O
cell	O
conditioned	O
medium	O
induces	O
oxidant	O
stress	O
leading	O
to	O
transendothelial	O
migration	O
of	O
monocytes	B-cell_type
.	O

The	O
abnormal	O
adherence	O
of	O
sickle	B-cell_type
red	I-cell_type
blood	I-cell_type
cells	I-cell_type
(	O
SS	B-cell_type
RBC	I-cell_type
)	O
to	O
endothelial	B-cell_type
cells	I-cell_type
has	O
been	O
thought	O
to	O
contribute	O
to	O
vascular	O
occlusion	O
,	O
a	O
major	O
cause	O
of	O
morbidity	O
in	O
sickle	O
cell	O
disease	O
(	O
SCD	O
)	O
.	O

We	O
determined	O
whether	O
the	O
interaction	O
of	O
SS	B-cell_type
RBC	I-cell_type
with	O
cultured	O
endothelial	B-cell_type
cells	I-cell_type
induced	O
cellular	O
oxidant	O
stress	O
that	O
would	O
culminate	O
in	O
expression	O
of	O
cell	B-protein
adhesion	I-protein
molecules	I-protein
(	O
CAMs	B-protein
)	O
involved	O
in	O
the	O
adhesion	O
and	O
diapedesis	O
of	O
monocytes	B-cell_type
and	O
the	O
adherence	O
of	O
SS	B-cell_type
reticulocytes	I-cell_type
.	O

We	O
showed	O
that	O
the	O
interaction	O
of	O
SS	B-cell_type
RBC	I-cell_type
at	O
2	O
%	O
concentration	O
in	O
the	O
presence	O
of	O
multimers	O
of	O
von	B-protein
Willebrand	I-protein
factor	I-protein
(	O
vWf	B-protein
)	O
,	O
derived	O
from	O
endothelial	O
cell-derived	O
conditioned	O
medium	O
(	O
E-CM	O
)	O
with	O
cultured	B-cell_line
human	I-cell_line
umbilical	I-cell_line
vein	I-cell_line
endothelial	I-cell_line
cells	I-cell_line
(	O
HUVEC	B-cell_line
)	O
,	O
resulted	O
in	O
a	O
fivefold	O
increased	O
formation	O
of	O
thiobarbituric	O
acid-reactive	O
substances	O
(	O
TBARS	O
)	O
and	O
activation	O
of	O
the	O
transcription	B-protein
factor	I-protein
NF-kB	B-protein
,	O
both	O
indicators	O
of	O
cellular	O
oxidant	O
stress	O
.	O

Normal	B-cell_type
RBC	I-cell_type
show	O
none	O
of	O
these	O
phenomena	O
.	O

The	O
oxidant	O
stress-induced	O
signaling	O
resulted	O
in	O
an	O
increased	O
surface	O
expression	O
of	O
a	O
subset	O
of	O
CAMs	B-protein
,	O
ICAM-1	B-protein
,	O
E-selectin	B-protein
,	O
and	O
VCAM-1	B-protein
in	O
HUVEC	B-cell_line
.	O

The	O
addition	O
of	O
oxygen	B-protein
radical	I-protein
scavenger	I-protein
enzymes	I-protein
(	O
catalase	B-protein
,	O
superoxide	B-protein
dismutase	I-protein
)	O
and	O
antioxidant	O
(	O
probucol	O
)	O
inhibited	O
these	O
events	O
.	O

Additionally	O
,	O
preincubation	O
of	O
HUVEC	B-cell_line
with	O
a	O
synthetic	O
peptide	O
Arg-Gly-Asp	O
(	O
RGD	O
)	O
that	O
prevents	O
vWf	B-protein
-mediated	O
adhesion	O
of	O
SS	B-cell_type
RBC	I-cell_type
reduced	O
the	O
surface	O
expression	O
of	O
VCAM-1	B-protein
and	O
NF-kB	B-protein
activation	O
.	O

Furthermore	O
,	O
SS	B-cell_type
RBC	I-cell_type
-induced	O
oxidant	O
stress	O
resulted	O
in	O
a	O
twofold	O
increase	O
in	O
the	O
transendothelial	O
migration	O
of	O
both	O
monocyte-like	B-cell_line
HL-60	I-cell_line
cells	I-cell_line
and	O
human	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
monocytes	I-cell_type
,	O
and	O
approximately	O
a	O
sixfold	O
increase	O
in	O
platelet-endothelial	B-protein
cell	I-protein
adhesion	I-protein
molecule-1	I-protein
(	O
PECAM-1	B-protein
)	O
phosphorylation	O
,	O
each	O
of	O
which	O
was	O
blocked	O
by	O
protein	B-protein
kinase	I-protein
C	I-protein
inhibitor	O
and	O
antioxidants	O
.	O

These	O
results	O
suggest	O
that	O
the	O
adherence/contact	O
of	O
SS	B-cell_type
RBC	I-cell_type
to	O
endothelial	B-cell_type
cells	I-cell_type
in	O
large	O
vessel	O
can	O
generate	O
enhanced	O
oxidant	O
stress	O
leading	O
to	O
increased	O
adhesion	O
and	O
diapedesis	O
of	O
monocytes	B-cell_type
,	O
as	O
well	O
as	O
heightened	O
adherence	O
of	O
SS	B-cell_type
reticulocytes	I-cell_type
,	O
indicating	O
that	O
injury/activation	O
of	O
endothelium	O
can	O
contribute	O
to	O
vaso-occlusion	O
in	O
SCD	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Interaction	NULL
of	NULL
Sickle	NULL
Erythrocytes	NULL
With	NULL
Endothelial	NULL
Cells	NULL
in	NULL
the	NULL
Presence	NULL
of	NULL
Endothelial	NULL
Cell	NULL
Conditioned	NULL
Medium	NULL
Induces	NULL
Oxidant	NULL
Stress	NULL
Leading	NULL
to	NULL
Transendothelial	NULL
Migration	NULL
of	NULL
Monocytes	NULL
By	NULL
Chand	NULL
Sultana	NULL
,	NULL
Yamin	NULL
Shen	NULL
,	NULL
Vinod	NULL
Rattan	NULL
,	NULL
Cage	NULL
Johnson	NULL
,	NULL
and	NULL
Vijay	NULL
K.	NULL
Kalra	NULL
The	NULL
abnormal	NULL
adherence	NULL
of	NULL
sickle	NULL
red	NULL
blood	NULL
cells	NULL
(	NULL
SS	NULL
RBC	NULL
)	NULL
to	NULL
endothelial	NULL
cells	NULL
has	NULL
been	NULL
thought	NULL
to	NULL
contribute	NULL
to	NULL
vascular	NULL
occlusion	NULL
,	NULL
a	NULL
major	NULL
cause	NULL
of	NULL
morbidity	NULL
in	NULL
sickle	NULL
cell	NULL
disease	NULL
(	NULL
SCD	NULL
)	NULL
.	NULL

We	NULL
determined	NULL
whether	NULL
the	NULL
interaction	NULL
of	NULL
SS	NULL
RBC	NULL
with	NULL
cultured	NULL
endothelial	NULL
cells	NULL
induced	NULL
cellular	NULL
oxidant	NULL
stress	NULL
that	NULL
would	NULL
culminate	NULL
in	NULL
expression	NULL
of	NULL
cell	NULL
adhesion	NULL
molecules	NULL
(	NULL
CAMs	NULL
)	NULL
involved	NULL
in	NULL
the	NULL
adhesion	NULL
and	NULL
diapedesis	NULL
of	NULL
monocytes	NULL
and	NULL
the	NULL
adherence	NULL
of	NULL
SS	NULL
reticulocytes	NULL
.	NULL

We	NULL
showed	NULL
that	NULL
the	NULL
interaction	NULL
of	NULL
SS	NULL
RBC	NULL
at	NULL
2	NULL
%	NULL
concentration	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
multimers	NULL
of	NULL
von	NULL
Willebrand	NULL
factor	NULL
(	NULL
vW1	NULL
)	NULL
,	NULL
derived	NULL
from	NULL
endothelial	NULL
cell-derived	NULL
conditioned	NULL
medium	NULL
(	NULL
E-CM	NULL
)	NULL
with	NULL
cultured	NULL
human	NULL
umbilical	NULL
vein	NULL
endothelial	NULL
cells	NULL
(	NULL
HUVEC	NULL
)	NULL
,	NULL
resulted	NULL
in	NULL
a	NULL
fivefold	NULL
increased	NULL
formation	NULL
of	NULL
thiobarbituric	NULL
acid-reactive	NULL
substances	NULL
(	NULL
TBARS	NULL
)	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
,	NULL
both	NULL
indicators	NULL
of	NULL
cellular	NULL
oxidant	NULL
stress	NULL
.	NULL

Normal	NULL
RBC	NULL
show	NULL
none	NULL
of	NULL
these	NULL
phenomena	NULL
.	NULL

The	NULL
oxidant	NULL
stress-induced	NULL
signaling	NULL
resulted	NULL
in	NULL
an	NULL
increased	NULL
surface	NULL
expression	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
CAMs	NULL
,	NULL
ICAM-1	NULL
,	NULL
E-selectin	NULL
,	NULL
and	NULL
VCAM-1	NULL
in	NULL
HUVEC	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
oxygen	NULL
NDOTHELIAL	NULL
CELLS	NULL
forming	NULL
the	NULL
lining	NULL
of	NULL
the	NULL
blood	NULL
vessels	NULL
throughout	NULL
the	NULL
vasculature	NULL
come	NULL
in	NULL
continuous	NULL
contact	NULL
with	NULL
circulating	NULL
blood	NULL
cells	NULL
and	NULL
plasma	NULL
components	NULL
.	NULL

Under	NULL
normal	NULL
physiological	NULL
conditions	NULL
,	NULL
blood	NULL
cells	NULL
are	NULL
,	NULL
at	NULL
most	NULL
,	NULL
loosely	NULL
attached	NULL
to	NULL
endothelial	NULL
cells	NULL
as	NULL
in	NULL
the	NULL
marginal	NULL
pools	NULL
of	NULL
polymorphonuclear	NULL
leukocytes	NULL
(	NULL
PMN	NULL
)	NULL
.	NULL

However	NULL
,	NULL
under	NULL
other	NULL
conditions	NULL
,	NULL
blood	NULL
cells	NULL
do	NULL
adhere	NULL
to	NULL
localized	NULL
vascular	NULL
sites	NULL
as	NULL
part	NULL
of	NULL
hemostasis	NULL
.	NULL

For	NULL
example	NULL
,	NULL
PMN	NULL
adhere	NULL
to	NULL
endothelium	NULL
before	NULL
they	NULL
migrate	NULL
to	NULL
sites	NULL
of	NULL
extravascular	NULL
infection	NULL
or	NULL
acute	NULL
inflammation	NULL
,	NULL
and	NULL
platelets	NULL
accumulate	NULL
at	NULL
injured	NULL
sites	NULL
in	NULL
the	NULL
vessels	NULL
.	NULL

These	NULL
are	NULL
normal	NULL
processes	NULL
required	NULL
for	NULL
host	NULL
defense	NULL
and	NULL
hemostasis	NULL
,	NULL
respectively	NULL
.	NULL
``	NULL

However	NULL
,	NULL
sickle	NULL
red	NULL
blood	NULL
cells	NULL
(	NULL
SS	NULL
RBC	NULL
)	NULL
from	NULL
patients	NULL
with	NULL
sickle	NULL
cell	NULL
anemia	NULL
exhibit	NULL
increased	NULL
adherence	NULL
to	NULL
cultured	NULL
endothelial	NULL
cells	NULL
under	NULL
both	NULL
static	NULL
and	NULL
flow	NULL
conditions*	NULL
``	NULL
and	NULL
the	NULL
extent	NULL
of	NULL
adhesion	NULL
in	NULL
vitro	NULL
appears	NULL
to	NULL
parallel	NULL
the	NULL
clinical	NULL
severity	NULL
of	NULL
vaso-occlusive	NULL
events	NULL
in	NULL
sickle	NULL
cell	NULL
disease	NULL
(	NULL
SCD	NULL
)	NULL
.	NULL
``	NULL

Such	NULL
abnormal	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
,	NULL
when	NULL
compared	NULL
with	NULL
the	NULL
behavior	NULL
of	NULL
normal	NULL
RBC	NULL
,	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
important	NULL
in	NULL
the	NULL
mechanism	NULL
of	NULL
vaso-occlusion	NULL
,	NULL
a	NULL
hallmark	NULL
of	NULL
sickle	NULL
cell	NULL
crises	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
to	NULL
adhesion	NULL
events	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
SS	NULL
RBC	NULL
with	NULL
endothelium	NULL
may	NULL
cause	NULL
From	NULL
the	NULL
Departments	NULL
of	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
and	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Southern	NULL
California	NULL
,	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
.	NULL

Submitted	NULL
March	NULL
24	NULL
,	NULL
1997	NULL
;	NULL
accepted	NULL
July	NULL
2	NULL
,	NULL
1998	NULL
.	NULL

Supported	NULL
by	NULL
National	NULL
Institute	NULL
of	NULL
Health	NULL
,	NULL
Heart	NULL
,	NULL
Lung	NULL
,	NULL
and	NULL
Blood	NULL
Institute	NULL
Grant	NULL
No	NULL
.	NULL

P6O-HL-48484	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Vijay	NULL
K.	NULL
Kalra	NULL
,	NULL
PhD	NULL
,	NULL
University	NULL
of	NULL
Southern	NULL
California	NULL
,	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
2250	NULL
Alcazar	NULL
St	NULL
,	NULL
CSC/1	NULL
GM	NULL
204	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
90033	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/98/9210-0009	NULL
$	NULL
3.00/0	NULL
3924	NULL
radical	NULL
scavenger	NULL
enzymes	NULL
(	NULL
catalase	NULL
,	NULL
superoxide	NULL
dismutase	NULL
)	NULL
and	NULL
antioxidant	NULL
(	NULL
probucol	NULL
)	NULL
inhibited	NULL
these	NULL
events	NULL
.	NULL

Additionally	NULL
,	NULL
preincubation	NULL
of	NULL
HUVEC	NULL
with	NULL
a	NULL
synthetic	NULL
peptide	NULL
Arg-Gly-Asp	NULL
(	NULL
RGD	NULL
)	NULL
that	NULL
prevents	NULL
vWf-mediated	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
reduced	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
VCAM-1	NULL
and	NULL
NF-kB	NULL
activation	NULL
.	NULL

Furthermore	NULL
,	NULL
SS	NULL
RBC-induced	NULL
oxidant	NULL
stress	NULL
resulted	NULL
in	NULL
a	NULL
twofold	NULL
increase	NULL
in	NULL
the	NULL
transendothelial	NULL
migration	NULL
of	NULL
both	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
and	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
,	NULL
and	NULL
approximately	NULL
a	NULL
sixfold	NULL
increase	NULL
in	NULL
platelet-endothelial	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
PECAM-1	NULL
)	NULL
phosphorylation	NULL
,	NULL
each	NULL
of	NULL
which	NULL
was	NULL
blocked	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
inhibitor	NULL
and	NULL
antioxidants	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
adherence/	NULL
contact	NULL
of	NULL
SS	NULL
RBC	NULL
to	NULL
endothelial	NULL
cells	NULL
in	NULL
large	NULL
vessel	NULL
can	NULL
generate	NULL
enhanced	NULL
oxidant	NULL
stress	NULL
leading	NULL
to	NULL
increased	NULL
adhesion	NULL
and	NULL
diapedesis	NULL
of	NULL
monocytes	NULL
,	NULL
as	NULL
well	NULL
as	NULL
heightened	NULL
adherence	NULL
of	NULL
SS	NULL
reticulocytes	NULL
,	NULL
indicating	NULL
that	NULL
injury/activation	NULL
of	NULL
endothelium	NULL
can	NULL
contribute	NULL
to	NULL
vaso-occlusion	NULL
in	NULL
SCD	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

endothelial	NULL
injury	NULL
,	NULL
culminating	NULL
in	NULL
the	NULL
dislodgment	NULL
of	NULL
cells	NULL
from	NULL
vessel	NULL
walls	NULL
or	NULL
the	NULL
altering	NULL
of	NULL
endothelium	NULL
characteristics	NULL
,	NULL
such	NULL
as	NULL
vascular	NULL
tone	NULL
.	NULL
``	NULL

''	NULL
It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
genes	NULL
coding	NULL
for	NULL
vasoconstrictor	NULL
endothelin-1	NULL
(	NULL
ET-1	NULL
)	NULL
'	NULL
``	NULL
are	NULL
induced	NULL
as	NULL
a	NULL
result	NULL
of	NULL
interaction	NULL
of	NULL
SS	NULL
RBC	NULL
with	NULL
endothelium	NULL
,	NULL
which	NULL
may	NULL
affect	NULL
vascular	NULL
tone	NULL
and	NULL
thus	NULL
affect	NULL
blood	NULL
flow	NULL
.	NULL
``	NULL

Because	NULL
SS	NULL
RBC	NULL
generate	NULL
excessive	NULL
amounts	NULL
of	NULL
reactive	NULL
oxygen	NULL
metabolites	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
unstable	NULL
hemoglobin	NULL
S	NULL
and	NULL
the	NULL
spontaneous	NULL
autoxidation	NULL
of	NULL
iron	NULL
in	NULL
heme	NULL
,	NULL
'*	NULL
``	NULL
``	NULL
we	NULL
hypothesized	NULL
that	NULL
the	NULL
adherence	NULL
of	NULL
SS	NULL
RBC	NULL
,	NULL
mediated	NULL
by	NULL
multimers	NULL
of	NULL
von	NULL
Willebrand	NULL
factor	NULL
(	NULL
vW1	NULL
)	NULL
,	NULL
to	NULL
cultured	NULL
endothelial	NULL
cells	NULL
might	NULL
induce	NULL
cellular	NULL
oxidant	NULL
stress	NULL
,	NULL
ie	NULL
,	NULL
generation	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
capable	NULL
of	NULL
activating	NULL
transcription	NULL
factor	NULL
,	NULL
NF-kB	NULL
.	NULL
'	NULL

''	NULL
Numerous	NULL
studies'*	NULL
``	NULL
``	NULL
have	NULL
shown	NULL
that	NULL
diverse	NULL
agents	NULL
,	NULL
eg	NULL
,	NULL
inflammatory	NULL
cytokines	NULL
,	NULL
oxidative	NULL
stress	NULL
(	NULL
hydrogen	NULL
peroxide	NULL
)	NULL
,	NULL
and	NULL
endotoxins	NULL
activate	NULL
NF-kB	NULL
by	NULL
distinct	NULL
intracellular	NULL
pathways	NULL
that	NULL
involve	NULL
reactive	NULL
oxygen	NULL
species	NULL
(	NULL
ROS	NULL
)	NULL
as	NULL
a	NULL
common	NULL
messenger	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
NF-kB	NULL
is	NULL
capable	NULL
of	NULL
altering	NULL
gene	NULL
expression	NULL
of	NULL
several	NULL
genes	NULL
including	NULL
those	NULL
for	NULL
the	NULL
cell-adhesion	NULL
molecules	NULL
(	NULL
ICAM-1	NULL
,	NULL
E-selectin	NULL
,	NULL
and	NULL
VCAM-1	NULL
)	NULL
.	NULL
'	NULL

5	NULL
``	NULL
``	NULL
As	NULL
a	NULL
consequence	NULL
of	NULL
the	NULL
increased	NULL
expression	NULL
of	NULL
cell-adhesion	NULL
molecules	NULL
,	NULL
the	NULL
adherence	NULL
of	NULL
PMN	NULL
and	NULL
monocytes	NULL
to	NULL
vascular	NULL
endothelium	NULL
might	NULL
be	NULL
heightened	NULL
.	NULL

Moreover	NULL
,	NULL
VCAM-1	NULL
acts	NULL
as	NULL
a	NULL
receptor	NULL
for	NULL
the	NULL
«	NULL
4B	NULL
;	NULL
integrin	NULL
present	NULL
on	NULL
SS	NULL
reticulocytes	NULL
``	NULL
thus	NULL
promoting	NULL
the	NULL
additional	NULL
adherence	NULL
of	NULL
SS	NULL
RBC	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
of	NULL
the	NULL
additional	NULL
adherence	NULL
of	NULL
SS	NULL
RBC	NULL
,	NULL
PMN	NULL
,	NULL
and	NULL
monocytes	NULL
,	NULL
blood	NULL
flow	NULL
could	NULL
be	NULL
further	NULL
obstructed	NULL
,	NULL
which	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
recurrent	NULL
vaso-occlusive	NULL
events	NULL
in	NULL
SCD	NULL
.	NULL

To	NULL
test	NULL
our	NULL
hypothesis	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
the	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
to	NULL
cultured	NULL
endothelial	NULL
cells	NULL
generated	NULL
ROS	NULL
,	NULL
and	NULL
if	NULL
so	NULL
,	NULL
whether	NULL
it	NULL
caused	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
of	NULL
activation	NULL
of	NULL
NF-kB	NULL
,	NULL
we	NULL
expect	NULL
to	NULL
find	NULL
increased	NULL
expression	NULL
of	NULL
VCAM-1	NULL
,	NULL
which	NULL
would	NULL
allow	NULL
adherence	NULL
of	NULL
sickle	NULL
reticulocytes	NULL
via	NULL
the	NULL
o4B	NULL
;	NULL
integrin	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
NF-kB	NULL
would	NULL
also	NULL
lead	NULL
to	NULL
increased	NULL
expression	NULL
of	NULL
CAMs	NULL
,	NULL
Blood	NULL
,	NULL
Vol	NULL
92	NULL
,	NULL
No	NULL
10	NULL
(	NULL
November	NULL
15	NULL
)	NULL
,	NULL
1998	NULL
:	NULL
pp	NULL
3924-3935	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

SS	NULL
RBC-INDUCED	NULL
OXIDANT	NULL
STRESS	NULL
IN	NULL
ENDOTHELIUM	NULL
which	NULL
participate	NULL
in	NULL
the	NULL
adhesion	NULL
of	NULL
monocytes	NULL
to	NULL
endothelial	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
adhesion	NULL
of	NULL
both	NULL
reticulocytes	NULL
and	NULL
monocytes	NULL
to	NULL
the	NULL
vascular	NULL
endothelium	NULL
could	NULL
cause	NULL
further	NULL
obstruction	NULL
and	NULL
participate	NULL
in	NULL
vaso-occlusive	NULL
phenomenon	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
the	NULL
interaction	NULL
of	NULL
SS	NULL
RBC	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
multimers	NULL
of	NULL
vWf	NULL
,	NULL
derived	NULL
from	NULL
endothelial	NULL
cell-derived	NULL
conditioned	NULL
medium	NULL
(	NULL
E-CM	NULL
)	NULL
with	NULL
cultured	NULL
human	NULL
umbilical	NULL
vein	NULL
endothelial	NULL
cells	NULL
(	NULL
HUVEC	NULL
)	NULL
,	NULL
indeed	NULL
results	NULL
in	NULL
an	NULL
increased	NULL
formation	NULL
of	NULL
thiobarbituric	NULL
acid-reactive	NULL
substances	NULL
(	NULL
TBARS	NULL
)	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
,	NULL
both	NULL
indices	NULL
of	NULL
cellular	NULL
oxidant	NULL
stress	NULL
.	NULL

'*	NULL
'	NULL
``	NULL
*	NULL
``	NULL
Furthermore	NULL
,	NULL
we	NULL
show	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
the	NULL
oxidant	NULL
stress	NULL
induced	NULL
by	NULL
the	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
causes	NULL
a	NULL
several-fold	NULL
increase	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
PECAM-1	NULL
,	NULL
a	NULL
multifunctional	NULL
cell-junction	NULL
molecule	NULL
,	NULL
``	NULL
>	NULL
``	NULL
``	NULL
and	NULL
importantly	NULL
,	NULL
a	NULL
concomitant	NULL
increase	NULL
in	NULL
the	NULL
migration	NULL
of	NULL
both	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
and	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
(	NULL
PBM	NULL
)	NULL
across	NULL
the	NULL
endothelial	NULL
cell	NULL
monolayer	NULL
.	NULL

In	NULL
SCD	NULL
,	NULL
the	NULL
accumulation	NULL
of	NULL
monocytes	NULL
in	NULL
large	NULL
vessels	NULL
,	NULL
eg	NULL
,	NULL
cerebral	NULL
vasculature	NULL
in	NULL
response	NULL
to	NULL
the	NULL
oxidant	NULL
stress	NULL
generated	NULL
by	NULL
the	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
,	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
stroke	NULL
syndrome	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Materials	NULL
.	NULL

-	NULL
``	NULL
P	NULL
[	NULL
carrier	NULL
free	NULL
]	NULL
was	NULL
obtained	NULL
from	NULL
ICN	NULL
Biomedical	NULL
Inc	NULL
(	NULL
Irvine	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
[	NULL
y-*P	NULL
]	NULL
JATP	NULL
(	NULL
adenosine	NULL
triphosphate	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Amersham	NULL
Corp	NULL
(	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

1	NULL
«	NULL
,	NULL
25-dihydroxyvitamin	NULL
Ds	NULL
,	NULL
Calyculin	NULL
A	NULL
,	NULL
and	NULL
SQ-22536	NULL
were	NULL
obtained	NULL
from	NULL
Biomol	NULL
Research	NULL
Laboratories	NULL
(	NULL
Plymouth	NULL
Meeting	NULL
,	NULL
PA	NULL
)	NULL
;	NULL
GF-109203X	NULL
was	NULL
obtained	NULL
from	NULL
Calbiochem-Novabiochem	NULL
International	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Acetylated	NULL
low-density	NULL
lipoprotein	NULL
(	NULL
LDL	NULL
)	NULL
labeled	NULL
with	NULL
1,1'-dioctadecy1-3,3,3',3'-tetramethylindocarbocyanine	NULL
perchlorate	NULL
was	NULL
obtained	NULL
from	NULL
Biomedical	NULL
Technologies	NULL
,	NULL
Inc	NULL
(	NULL
Stoughton	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Monoclonal	NULL
antibodies	NULL
(	NULL
MoAb	NULL
)	NULL
to	NULL
ICAM-1	NULL
,	NULL
ICAM-2	NULL
,	NULL
E-selectin	NULL
,	NULL
VCAM-1	NULL
,	NULL
and	NULL
PECAM-1	NULL
were	NULL
obtained	NULL
from	NULL
Immunotech	NULL
Inc	NULL
(	NULL
Westbrook	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

A	NULL
MoAb	NULL
to	NULL
bovine	NULL
PECAM-1	NULL
,	NULL
a	NULL
purified	NULL
ascites	NULL
fluid	NULL
from	NULL
clones	NULL
was	NULL
prepared	NULL
as	NULL
described	NULL
.	NULL

``	NULL
?	NULL

All	NULL
other	NULL
reagents	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
(	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
unless	NULL
otherwise	NULL
specified	NULL
.	NULL

Isolation	NULL
of	NULL
RBC	NULL
from	NULL
whole	NULL
blood	NULL
.	NULL

Fresh	NULL
heparinized	NULL
or	NULL
citrated	NULL
blood	NULL
was	NULL
obtained	NULL
from	NULL
adult	NULL
sickle	NULL
cell	NULL
anemia	NULL
patients	NULL
(	NULL
homozygous	NULL
SS	NULL
)	NULL
and	NULL
sickle	NULL
cell	NULL
trait	NULL
subjects	NULL
(	NULL
AS	NULL
)	NULL
in	NULL
the	NULL
adult	NULL
clinic	NULL
of	NULL
the	NULL
Comprehensive	NULL
Sickle	NULL
Cell	NULL
Center	NULL
,	NULL
LAC-USC	NULL
Hospital	NULL
(	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
or	NULL
from	NULL
normal	NULL
(	NULL
AA	NULL
)	NULL
healthy	NULL
volunteers	NULL
(	NULL
ages	NULL
25	NULL
to	NULL
37	NULL
years	NULL
)	NULL
after	NULL
obtaining	NULL
informed	NULL
consent	NULL
according	NULL
to	NULL
a	NULL
protocol	NULL
approved	NULL
by	NULL
the	NULL
Institution	NULL
Review	NULL
Committee	NULL
.	NULL

Sickle	NULL
cell	NULL
patients	NULL
who	NULL
had	NULL
received	NULL
blood	NULL
transfusions	NULL
within	NULL
3	NULL
months	NULL
were	NULL
excluded	NULL
from	NULL
these	NULL
studies	NULL
.	NULL

Whole	NULL
blood	NULL
(	NULL
8	NULL
to	NULL
10	NULL
mL	NULL
)	NULL
was	NULL
centrifuged	NULL
at	NULL
450g	NULL
for	NULL
20	NULL
minutes	NULL
.	NULL

Plasma	NULL
and	NULL
buffy	NULL
coat	NULL
were	NULL
removed	NULL
by	NULL
aspiration	NULL
.	NULL

The	NULL
pellet	NULL
was	NULL
suspended	NULL
in	NULL
3	NULL
volumes	NULL
of	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
and	NULL
passed	NULL
through	NULL
a	NULL
column	NULL
(	NULL
3.5	NULL
cm	NULL
in	NULL
a	NULL
30	NULL
mL	NULL
syringe	NULL
)	NULL
of	NULL
cellulose-microcrystalline	NULL
cellulose	NULL
(	NULL
wt/wt	NULL
1:1	NULL
)	NULL
as	NULL
described	NULL
.	NULL
``	NULL

The	NULL
eluted	NULL
fraction	NULL
was	NULL
passed	NULL
twice	NULL
through	NULL
a	NULL
new	NULL
column	NULL
of	NULL
cellulose-microcrystalline	NULL
cellulose	NULL
(	NULL
1:1	NULL
wt/wt	NULL
)	NULL
to	NULL
remove	NULL
platelets	NULL
and	NULL
white	NULL
blood	NULL
cells	NULL
(	NULL
WBC	NULL
)	NULL
.	NULL

The	NULL
eluate	NULL
was	NULL
centrifuged	NULL
at	NULL
450g	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

The	NULL
pellet	NULL
of	NULL
RBC	NULL
was	NULL
resuspended	NULL
in	NULL
2	NULL
mL	NULL
of	NULL
PBS	NULL
for	NULL
differential	NULL
count	NULL
by	NULL
the	NULL
MINOS-STX	NULL
automatic	NULL
cell	NULL
analyzer	NULL
(	NULL
Roche	NULL
Diagnostic	NULL
Systems	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

By	NULL
this	NULL
method	NULL
,	NULL
we	NULL
routinely	NULL
obtained	NULL
RBC	NULL
preparations	NULL
that	NULL
were	NULL
less	NULL
than	NULL
1	NULL
%	NULL
contaminated	NULL
by	NULL
platelets	NULL
and	NULL
WBC	NULL
.	NULL

Isolation	NULL
of	NULL
human	NULL
PBM	NULL
.	NULL

-	NULL
Blood	NULL
(	NULL
80	NULL
to	NULL
100	NULL
mL	NULL
)	NULL
was	NULL
collected	NULL
by	NULL
venipuncture	NULL
from	NULL
adult	NULL
donors	NULL
of	NULL
both	NULL
sexes	NULL
.	NULL

To	NULL
the	NULL
whole	NULL
blood	NULL
collected	NULL
into	NULL
a	NULL
heparinized	NULL
60	NULL
mL	NULL
plastic	NULL
syringe	NULL
was	NULL
added	NULL
Dextran	NULL
(	NULL
13.5	NULL
mL	NULL
of	NULL
5	NULL
%	NULL
Dextran	NULL
)	NULL
followed	NULL
by	NULL
gravity	NULL
sedimentation	NULL
for	NULL
40	NULL
3925	NULL
minutes	NULL
as	NULL
described	NULL
.	NULL
``	NULL

The	NULL
supernatant	NULL
containing	NULL
leukocytes	NULL
were	NULL
fractionated	NULL
into	NULL
monocytes	NULL
by	NULL
gradient	NULL
centrifugation	NULL
on	NULL
Isolymph	NULL
.	NULL

The	NULL
monocyte	NULL
fraction	NULL
was	NULL
labeled	NULL
with	NULL
MO2-FITC	NULL
antibody	NULL
(	NULL
Coulter	NULL
Diagnostics	NULL
,	NULL
Hialeah	NULL
,	NULL
FL	NULL
)	NULL
followed	NULL
by	NULL
FACscan	NULL
analysis	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Cells	NULL
obtained	NULL
by	NULL
this	NULL
procedure	NULL
had	NULL
purity	NULL
in	NULL
the	NULL
range	NULL
of	NULL
70	NULL
%	NULL
to	NULL
85	NULL
%	NULL
and	NULL
a	NULL
yield	NULL
of	NULL
50	NULL
%	NULL
to	NULL
75	NULL
%	NULL
.	NULL

Cell	NULL
cultures	NULL
.	NULL

HUVEC	NULL
were	NULL
harvested	NULL
from	NULL
umbilical	NULL
cord	NULL
veins	NULL
by	NULL
collagenase	NULL
digestion	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

The	NULL
cells	NULL
were	NULL
evaluated	NULL
for	NULL
cobblestone	NULL
morphology	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
vWF-antibody	NULL
,	NULL
and	NULL
the	NULL
uptake	NULL
of	NULL
acetylated	NULL
LDL	NULL
labeled	NULL
with	NULL
1,1	NULL
'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine	NULL
perchlorate	NULL
.	NULL

Cells	NULL
were	NULL
used	NULL
from	NULL
passages	NULL
two	NULL
through	NULL
six	NULL
.	NULL

The	NULL
human	NULL
promyelocytic	NULL
cell	NULL
line	NULL
HL-60	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
was	NULL
cultured	NULL
in	NULL
RPMI-1640	NULL
containing	NULL
20	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Gemini	NULL
Bioproducts	NULL
,	NULL
Calabasas	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

HL-60	NULL
cells	NULL
differentiate	NULL
to	NULL
a	NULL
monocyte-like	NULL
phenotype	NULL
by	NULL
incubation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
X	NULL
107	NULL
mol/L	NULL
1e-25-dihydroxyvitamin	NULL
D	NULL
;	NULL
after	NULL
3	NULL
to	NULL
4	NULL
days	NULL
under	NULL
culture	NULL
conditions	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

''	NULL
``	NULL
``	NULL
Preparation	NULL
of	NULL
E-CM	NULL
.	NULL

To	NULL
the	NULL
HUVEC	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
grown	NULL
to	NULL
confluence	NULL
,	NULL
3	NULL
mL	NULL
of	NULL
RPMI-1640	NULL
(	NULL
devoid	NULL
of	NULL
fetal	NULL
bovine	NULL
serum	NULL
)	NULL
,	NULL
1	NULL
mmol/L	NULL
CaC	NULL
)	NULL
;	NULL
,	NULL
and	NULL
10	NULL
umol/L	NULL
A23187	NULL
calcium	NULL
ionophore	NULL
were	NULL
added	NULL
followed	NULL
by	NULL
incubation	NULL
for	NULL
2	NULL
hours	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL
``	NULL

The	NULL
supernatant	NULL
was	NULL
collected	NULL
and	NULL
concentrated	NULL
in	NULL
dialysis	NULL
tubing	NULL
.	NULL

The	NULL
concentrated	NULL
sample	NULL
was	NULL
subjected	NULL
to	NULL
an	NULL
agarose	NULL
(	NULL
2.5	NULL
%	NULL
)	NULL
gel	NULL
electrophoresis	NULL
in	NULL
a	NULL
running	NULL
buffer	NULL
containing	NULL
25	NULL
mmol/L	NULL
Tris	NULL
buffer	NULL
,	NULL
pH	NULL
8.3	NULL
,	NULL
0.192	NULL
mol/L	NULL
glycine	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
sizes	NULL
of	NULL
vWf	NULL
multimers	NULL
were	NULL
estimated	NULL
by	NULL
comparison	NULL
with	NULL
Jack	NULL
bean	NULL
urease	NULL
as	NULL
a	NULL
standard	NULL
(	NULL
Mr.	NULL
240	NULL
and	NULL
480	NULL
kD	NULL
,	NULL
Sigma	NULL
)	NULL
after	NULL
staining	NULL
the	NULL
gel	NULL
with	NULL
0.25	NULL
%	NULL
Coomassie	NULL
brilliant	NULL
blue	NULL
dye	NULL
.	NULL

The	NULL
analysis	NULL
of	NULL
conditioned	NULL
medium	NULL
showed	NULL
triplet	NULL
bands	NULL
of	NULL
high-molecular	NULL
weight	NULL
polypeptides	NULL
to	NULL
be	NULL
estimated	NULL
in	NULL
the	NULL
range	NULL
of	NULL
400	NULL
to	NULL
950	NULL
kD	NULL
that	NULL
cross-reacted	NULL
with	NULL
antibody	NULL
to	NULL
vWf	NULL
as	NULL
has	NULL
been	NULL
previously	NULL
observed	NULL
.	NULL
``	NULL

We	NULL
used	NULL
E-CM	NULL
at	NULL
100	NULL
ug/mL	NULL
for	NULL
the	NULL
studies	NULL
described	NULL
here	NULL
because	NULL
this	NULL
concentration	NULL
showed	NULL
optimal	NULL
adherence	NULL
of	NULL
SS	NULL
RBC	NULL
to	NULL
HUVEC	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Measurement	NULL
of	NULL
lipid	NULL
peroxides	NULL
as	NULL
thiobarbituric	NULL
acid-reactive	NULL
substances	NULL
(	NULL
TBARS	NULL
)	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

-	NULL
Confluent	NULL
HUVEC	NULL
(	NULL
2.5	NULL
%	NULL
105	NULL
cells	NULL
in	NULL
100	NULL
mm	NULL
tissue	NULL
culture	NULL
dishes	NULL
)	NULL
were	NULL
washed	NULL
with	NULL
RPML-1640	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
RBC	NULL
(	NULL
hematocrit	NULL
2	NULL
%	NULL
)	NULL
with	NULL
E-CM	NULL
(	NULL
100	NULL
ug/mL	NULL
)	NULL
in	NULL
3	NULL
mL	NULL
serum-free	NULL
RPMI-1640	NULL
for	NULL
4	NULL
hours	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
incubation	NULL
,	NULL
nonadherent	NULL
RBC	NULL
were	NULL
aspirated	NULL
and	NULL
plates	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
3	NULL
mL	NULL
of	NULL
PBS	NULL
.	NULL

Endothelial	NULL
cells	NULL
were	NULL
harvested	NULL
from	NULL
the	NULL
culture	NULL
dish	NULL
by	NULL
treatment	NULL
with	NULL
a	NULL
0.25	NULL
%	NULL
trypsin-0.02	NULL
%	NULL
EDTA	NULL
solution	NULL
.	NULL

The	NULL
contents	NULL
were	NULL
centrifuged	NULL
at	NULL
500g	NULL
for	NULL
5	NULL
minutes	NULL
at	NULL
4°C	NULL
.	NULL

Cell	NULL
pellets	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
TBS	NULL
(	NULL
10	NULL
mmol/L	NULL
Tris-buffer	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
containing	NULL
140	NULL
mmol/L	NULL
NaCl	NULL
)	NULL
.	NULL

The	NULL
content	NULL
of	NULL
lipid	NULL
peroxides	NULL
formed	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
reactivity	NULL
of	NULL
malondi-aldehyde	NULL
(	NULL
MDA	NULL
)	NULL
,	NULL
an	NULL
end	NULL
product	NULL
of	NULL
lipid	NULL
peroxidation	NULL
,	NULL
with	NULL
thiobarbituric	NULL
acid	NULL
(	NULL
TBA	NULL
)	NULL
as	NULL
described	NULL
.	NULL

``	NULL
*	NULL
Briefly	NULL
,	NULL
0.8	NULL
mL	NULL
of	NULL
water	NULL
was	NULL
added	NULL
to	NULL
the	NULL
pellet	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
0.2	NULL
mL	NULL
of	NULL
8.1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
,	NULL
1.5	NULL
mL	NULL
of	NULL
20	NULL
%	NULL
acetic	NULL
acid	NULL
,	NULL
and	NULL
1.5	NULL
mL	NULL
.	NULL

of	NULL
a	NULL
0.8	NULL
%	NULL
aqueous	NULL
solution	NULL
of	NULL
TBA	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
heated	NULL
for	NULL
60	NULL
minutes	NULL
in	NULL
a	NULL
boiling	NULL
water	NULL
bath	NULL
.	NULL

After	NULL
cooling	NULL
,	NULL
1	NULL
mL	NULL
of	NULL
water	NULL
and	NULL
5	NULL
mL	NULL
of	NULL
a	NULL
mixture	NULL
of	NULL
n-butanol-pyridine	NULL
(	NULL
15:1	NULL
vol/vol	NULL
)	NULL
were	NULL
added	NULL
.	NULL

Contents	NULL
were	NULL
vortexed	NULL
,	NULL
then	NULL
centrifuged	NULL
at	NULL
3,000g	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

The	NULL
upper	NULL
(	NULL
organic	NULL
)	NULL
layer	NULL
was	NULL
removed	NULL
for	NULL
measurement	NULL
of	NULL
absorbency	NULL
at	NULL
532	NULL
nm	NULL
(	NULL
Hitachi	NULL
U-3110	NULL
spectrophotometer	NULL
;	NULL
Hitachi	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
TBARS	NULL
values	NULL
were	NULL
calculated	NULL
using	NULL
the	NULL
molar	NULL
extinction	NULL
coefficient	NULL
of	NULL
the	NULL
MDA-TBA	NULL
complex	NULL
of	NULL
1.5	NULL
X	NULL
105	NULL
cm	NULL
``	NULL
'	NULL
M	NULL
``	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Static	NULL
assay	NULL
for	NULL
the	NULL
adherence	NULL
of	NULL
RBC	NULL
to	NULL
cultured	NULL
HUVEC	NULL
.	NULL

RBC	NULL
in	NULL
PBS	NULL
(	NULL
2	NULL
mL	NULL
at	NULL
Het	NULL
of	NULL
10	NULL
%	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
``	NULL
Cr-sodium	NULL
chromate	NULL
(	NULL
0.5	NULL
mCi	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
60	NULL
minutes	NULL
.	NULL

Labeled	NULL
RBC	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
10	NULL
vol	NULL
of	NULL
PBS	NULL
and	NULL
used	NULL
at	NULL
a	NULL
hematocrit	NULL
of	NULL
2	NULL
%	NULL
in	NULL
PBS	NULL
.	NULL

HUVEC	NULL
grown	NULL
to	NULL
confluence	NULL
in	NULL
6-well	NULL
plates	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
(	NULL
3	NULL
mL	NULL
)	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
*'Cr-labeled	NULL
RBC	NULL
(	NULL
Het	NULL
2	NULL
%	NULL
)	NULL
and	NULL
PBS	NULL
to	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
1	NULL
mL	NULL
.	NULL

The	NULL
contents	NULL
were	NULL
incubated	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3926	NULL
Table	NULL
1	NULL
.	NULL

Adhesion	NULL
of	NULL
RBC	NULL
to	NULL
HUVEC	NULL
and	NULL
the	NULL
Formation	NULL
of	NULL
Lipid	NULL
Peroxides	NULL
Treatment	NULL
of	NULL
nmole	NULL
MDA/1O®	NULL
-	NULL
Adherence	NULL
HUVEC	NULL
Inhibitor	NULL
HUVEC	NULL
h	NULL
of	NULL
RBC	NULL
(	NULL
%	NULL
)	NULL
None	NULL
-	NULL
8.4	NULL
+	NULL
1.3	NULL
EC-CM	NULL
(	NULL
100	NULL
pg/mL	NULL
)	NULL
-	NULL
8.7	NULL
+	NULL
0.6	NULL
AA	NULL
RBC	NULL
-	NULL
10.8	NULL
+	NULL
3.2	NULL
0.3	NULL
+	NULL
0.1	NULL
AA	NULL
RBC	NULL
+	NULL
E-CM	NULL
-	NULL
11.5	NULL
+	NULL
3.5	NULL
0.5	NULL
+	NULL
0.15	NULL
SS	NULL
RBC	NULL
-	NULL
30.3	NULL
+	NULL
5.5	NULL
0.8	NULL
+	NULL
0.2	NULL
SS	NULL
RBC	NULL
+	NULL
E-CM	NULL
(	NULL
50	NULL
ug/mL	NULL
)	NULL
-	NULL
ND	NULL
1.4	NULL
+	NULL
0.3	NULL
SS	NULL
RBC	NULL
+	NULL
E-CM	NULL
(	NULL
100	NULL
pg/mL	NULL
)	NULL
-	NULL
54.2	NULL
+	NULL
4.0	NULL
2.9	NULL
+	NULL
0.4	NULL
SS	NULL
RBC	NULL
+	NULL
E-CM	NULL
(	NULL
200	NULL
ug/m	NULL
L	NULL
)	NULL
-	NULL
56.0	NULL
+	NULL
5.5	NULL
2.9	NULL
+	NULL
0.5	NULL
SS	NULL
RBC	NULL
+	NULL
E-CM	NULL
(	NULL
100	NULL
pg/mL	NULL
)	NULL
KYRGDS	NULL
24.0	NULL
+	NULL
7.4	NULL
0.9	NULL
+	NULL
0.2	NULL
SS	NULL
RBC	NULL
+	NULL
E-CM	NULL
(	NULL
100	NULL
pg/mL	NULL
)	NULL
AGDV	NULL
51.4	NULL
+	NULL
4.1	NULL
2.8	NULL
+	NULL
0.3	NULL
SS	NULL
RBC	NULL
+	NULL
E-CM	NULL
(	NULL
100	NULL
pg/mL	NULL
)	NULL
SOD	NULL
+	NULL
Catalase	NULL
17.3	NULL
+	NULL
3.5	NULL
ND	NULL
SS	NULL
RBC	NULL
+	NULL
E-CM	NULL
(	NULL
100	NULL
pg/mL	NULL
)	NULL
Ab-vWF	NULL
ND	NULL
1.2	NULL
+	NULL
0.2	NULL
HUVEC	NULL
monolayer	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
RBC	NULL
(	NULL
2	NULL
%	NULL
Hct	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
E-CM	NULL
for	NULL
4	NULL
hours	NULL
.	NULL

Where	NULL
indicated	NULL
synthetic	NULL
peptides	NULL
(	NULL
KYRGDS	NULL
or	NULL
AGDV	NULL
[	NULL
100	NULL
pmol/L	NULL
]	NULL
;	NULL
free-radical	NULL
scavengers	NULL
(	NULL
superoxide	NULL
dismutase	NULL
[	NULL
200	NULL
U/mL	NULL
]	NULL
)	NULL
and	NULL
catalase	NULL
(	NULL
200	NULL
U/mL	NULL
)	NULL
;	NULL
or	NULL
antibody	NULL
(	NULL
vWf	NULL
,	NULL
5	NULL
pg/mL	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
HUVEC	NULL
for	NULL
30	NULL
minutes	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
RBC	NULL
.	NULL

Nonadherent	NULL
RBC	NULL
were	NULL
removed	NULL
by	NULL
aspiration	NULL
and	NULL
HUVEC	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
lipid	NULL
peroxides	NULL
ie	NULL
,	NULL
MDA	NULL
formed	NULL
in	NULL
HUVEC	NULL
was	NULL
determined	NULL
by	NULL
reaction	NULL
with	NULL
TBA	NULL
.	NULL

Incubation	NULL
of	NULL
SS	NULL
RBC	NULL
(	NULL
2	NULL
%	NULL
Hct	NULL
)	NULL
alone	NULL
in	NULL
buffer	NULL
at	NULL
37°C	NULL
for	NULL
2	NULL
or	NULL
4	NULL
hours	NULL
did	NULL
not	NULL
show	NULL
the	NULL
formation	NULL
of	NULL
MDA	NULL
,	NULL
as	NULL
its	NULL
formation	NULL
was	NULL
below	NULL
the	NULL
limit	NULL
of	NULL
detection	NULL
by	NULL
the	NULL
MDA	NULL
assay	NULL
used	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
adherence	NULL
of	NULL
RBC	NULL
was	NULL
determined	NULL
by	NULL
incubation	NULL
of	NULL
``	NULL
'Cr-labeled	NULL
RBC	NULL
with	NULL
HUVEC	NULL
monolayer	NULL
.	NULL

Results	NULL
are	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
AA	NULL
RBC	NULL
(	NULL
n	NULL
=	NULL
4	NULL
)	NULL
and	NULL
SS	NULL
RBC	NULL
(	NULL
n	NULL
=	NULL
4	NULL
)	NULL
of	NULL
duplicate	NULL
determinations	NULL
.	NULL

Abbreviation	NULL
:	NULL
ND	NULL
,	NULL
not	NULL
determined	NULL
.	NULL

for	NULL
45	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Nonadherent	NULL
RBC	NULL
were	NULL
removed	NULL
by	NULL
aspiration	NULL
and	NULL
monolayers	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
1	NULL
mL	NULL
of	NULL
PBS	NULL
containing	NULL
0.5	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
.	NULL

The	NULL
radioactivity	NULL
in	NULL
the	NULL
cell	NULL
monolayer-containing	NULL
adherent	NULL
RBC	NULL
was	NULL
determined	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
RBC	NULL
adherent	NULL
was	NULL
calculated	NULL
.	NULL
``	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
for	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
activity	NULL
.	NULL

-	NULL
Confluent	NULL
HUVEC	NULL
(	NULL
6	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
with	NULL
RBC	NULL
(	NULL
2	NULL
%	NULL
hematocrit	NULL
)	NULL
from	NULL
either	NULL
sickle	NULL
cell	NULL
anemia	NULL
(	NULL
SS	NULL
)	NULL
or	NULL
normal	NULL
(	NULL
AA	NULL
)	NULL
subjects	NULL
in	NULL
3	NULL
mL	NULL
serum-free	NULL
RPMI-1640	NULL
containing	NULL
E-CM	NULL
(	NULL
100	NULL
ug/mL	NULL
)	NULL
for	NULL
time	NULL
periods	NULL
ranging	NULL
from	NULL
30	NULL
to	NULL
240	NULL
minutes	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
incubation	NULL
period	NULL
,	NULL
the	NULL
medium	NULL
was	NULL
aspirated	NULL
and	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
3	NULL
mL	NULL
ice-cold	NULL
PBS	NULL
.	NULL

Cells	NULL
were	NULL
scraped	NULL
in	NULL
1	NULL
mL	NULL
PBS	NULL
and	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
as	NULL
described	NULL
.	NULL
``	NULL

'	NULL
Briefly	NULL
,	NULL
cells	NULL
were	NULL
suspended	NULL
in	NULL
400	NULL
uL	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mmol/L	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
1.5	NULL
mmol/L	NULL
MgC	NULL
]	NULL
;	NULL
,	NULL
10	NULL
mmol/L	NULL
KCI	NULL
,	NULL
1	NULL
mmol/L	NULL
dithiothreitol	NULL
(	NULL
DTT	NULL
)	NULL
,	NULL
0.5	NULL
mmol/L	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
(	NULL
PMSF	NULL
)	NULL
,	NULL
0.3	NULL
ug/mL	NULL
leupeptin	NULL
,	NULL
and	NULL
0.7	NULL
ug/mL	NULL
pepstatin	NULL
A	NULL
)	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

Cells	NULL
were	NULL
pelleted	NULL
and	NULL
resuspended	NULL
in	NULL
50	NULL
uL	NULL
of	NULL
buffer	NULL
B	NULL
(	NULL
20	NULL
mmol/L	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
420	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
1.5	NULL
mmol/L	NULL
MgCl	NULL
,	NULL
,	NULL
0.2	NULL
mmol/L	NULL
Na-EDTA	NULL
,	NULL
1	NULL
mmol/L	NULL
DTT	NULL
,	NULL
0.5	NULL
mmol/L	NULL
PMSF	NULL
;	NULL
0.3	NULL
ug/mL	NULL
leupeptin	NULL
,	NULL
and	NULL
0.7	NULL
ug/mL	NULL
pepstatin	NULL
A	NULL
)	NULL
.	NULL

After	NULL
a	NULL
20-minute	NULL
incubation	NULL
at	NULL
4°C	NULL
,	NULL
the	NULL
homogenate	NULL
was	NULL
centrifuged	NULL
at	NULL
8,000g	NULL
for	NULL
20	NULL
minutes	NULL
.	NULL

The	NULL
supernatant	NULL
,	NULL
containing	NULL
the	NULL
nuclear	NULL
proteins	NULL
,	NULL
was	NULL
stored	NULL
at	NULL
-80°C	NULL
,	NULL
and	NULL
used	NULL
for	NULL
assay	NULL
of	NULL
NF-kB	NULL
activity	NULL
within	NULL
10	NULL
days	NULL
of	NULL
storage	NULL
.	NULL

Five	NULL
nanograms	NULL
of	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
tandem	NULL
repeat	NULL
of	NULL
the	NULL
consensus	NULL
sequence	NULL
SULTANA	NULL
ET	NULL
AL	NULL
of	NULL
the	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
site	NULL
,	NULL
-GGGGACTTTCC-with	NULL
the	NULL
following	NULL
sequence	NULL
:	NULL
5-GATCCAAGGGGACTTTCCATGGATCCAAGGGGACTTTCC-ATG-3	NULL
'	NULL
3'-GTTCCCCTGAAAGGTACCTAGGTTCCCCTGAAAGGTACC-TAG-5	NULL
'	NULL
was	NULL
end	NULL
labeled	NULL
with	NULL
100	NULL
uCi	NULL
ATP	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
as	NULL
suggested	NULL
in	NULL
the	NULL
manufacturer	NULL
's	NULL
kit	NULL
(	NULL
GIBCO-BRL	NULL
,	NULL
Gaithers-burg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

DNA-protein-binding	NULL
reactions	NULL
were	NULL
performed	NULL
by	NULL
preincu-bating	NULL
3	NULL
to	NULL
5	NULL
ug	NULL
nuclear	NULL
extract	NULL
protein	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
minutes	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
25	NULL
uL	NULL
containing	NULL
10	NULL
mmol/L	NULL
Tris	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
50	NULL
mmol/L	NULL
NaCI	NULL
,	NULL
1	NULL
mmol/L	NULL
DTT	NULL
,	NULL
0.02	NULL
umol/L	NULL
ATP	NULL
,	NULL
5	NULL
ug	NULL
BSA	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
excess	NULL
specific-competitor	NULL
oligonucleotide	NULL
.	NULL

This	NULL
was	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
double-stranded	NULL
``	NULL
P-labeled	NULL
oligonucleotide	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
cpm	NULL
)	NULL
and	NULL
a	NULL
second	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
minutes	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
on	NULL
6	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gels	NULL
as	NULL
previously	NULL
de-scribed	NULL
``	NULL
using	NULL
0.25	NULL
X	NULL
TBE	NULL
running	NULL
buffer	NULL
containing	NULL
Tris	NULL
(	NULL
25	NULL
mmol/L	NULL
;	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
borate	NULL
(	NULL
22.5	NULL
mmol/L	NULL
)	NULL
,	NULL
and	NULL
EDTA	NULL
(	NULL
0.025	NULL
mmol/L	NULL
)	NULL
at	NULL
150	NULL
V	NULL
for	NULL
2	NULL
to	NULL
3	NULL
hours	NULL
.	NULL

Gels	NULL
were	NULL
then	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
X-Omat	NULL
AR	NULL
film	NULL
(	NULL
Eastman	NULL
Kodak	NULL
,	NULL
Rochester	NULL
,	NULL
NY	NULL
)	NULL
with	NULL
intensifying	NULL
screens	NULL
at	NULL
-80°C	NULL
.	NULL

Enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
for	NULL
surface	NULL
expression	NULL
of	NULL
CAMs	NULL
.	NULL

-	NULL
HUVEC	NULL
were	NULL
grown	NULL
to	NULL
confluence	NULL
in	NULL
24-well	NULL
tissue	NULL
culture	NULL
plates	NULL
,	NULL
rinsed	NULL
with	NULL
RPMI-1640	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
serum-free	NULL
RPMI-1640	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
RBC	NULL
(	NULL
hematocrit	NULL
2	NULL
%	NULL
)	NULL
with	NULL
E-CM	NULL
at	NULL
37°C	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
indicated	NULL
incubation	NULL
periods	NULL
,	NULL
ranging	NULL
from	NULL
2	NULL
to	NULL
24	NULL
hours	NULL
,	NULL
the	NULL
medium	NULL
was	NULL
aspirated	NULL
and	NULL
the	NULL
wells	NULL
washed	NULL
twice	NULL
with	NULL
1	NULL
mL	NULL
of	NULL
PBS	NULL
.	NULL

To	NULL
each	NULL
well	NULL
,	NULL
500	NULL
uL	NULL
of	NULL
2.5	NULL
%	NULL
paraformaldehyde	NULL
was	NULL
added	NULL
to	NULL
fix	NULL
the	NULL
cells	NULL
.	NULL

Cell-surface	NULL
expression	NULL
of	NULL
ICAM-1	NULL
,	NULL
E-selectin	NULL
,	NULL
and	NULL
VCAM-1	NULL
in	NULL
HUVEC	NULL
was	NULL
assayed	NULL
by	NULL
separate	NULL
incubations	NULL
with	NULL
MoAb	NULL
to	NULL
ICAM-1	NULL
,	NULL
E-selectin	NULL
,	NULL
and	NULL
VCAM-1	NULL
.	NULL

Incubations	NULL
were	NULL
performed	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
120	NULL
minutes	NULL
at	NULL
a	NULL
saturating	NULL
concentration	NULL
of	NULL
antibody	NULL
(	NULL
1:500	NULL
dilution	NULL
in	NULL
0.5	NULL
mL	NULL
of	NULL
PBS	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
,	NULL
then	NULL
incubated	NULL
with	NULL
alkaline	NULL
phosphatase-conjugated	NULL
goat	NULL
antimouse	NULL
IgG	NULL
,	NULL
diluted	NULL
1:1000	NULL
in	NULL
PBS	NULL
,	NULL
for	NULL
60	NULL
minutes	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
1	NULL
mL	NULL
of	NULL
PBS	NULL
.	NULL

Binding	NULL
of	NULL
the	NULL
secondary	NULL
antibody	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
200	NULL
uL	NULL
of	NULL
p-nitrophenyl	NULL
phosphate	NULL
substrate	NULL
(	NULL
1	NULL
mg/mL	NULL
in	NULL
0.2	NULL
mol/L	NULL
Tris	NULL
,	NULL
pH	NULL
9.8	NULL
,	NULL
containing	NULL
5	NULL
mmol/L	NULL
MgC	NULL
]	NULL
;	NULL
)	NULL
.	NULL

Plates	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
minutes	NULL
in	NULL
the	NULL
dark	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
50	NULL
uL	NULL
of	NULL
3N	NULL
NaOH	NULL
.	NULL

The	NULL
absorbency	NULL
was	NULL
read	NULL
at	NULL
405	NULL
nm	NULL
in	NULL
an	NULL
ELISA	NULL
plate	NULL
reader	NULL
(	NULL
Model	NULL
7520	NULL
;	NULL
Cambridge	NULL
Technology	NULL
,	NULL
Watertown	NULL
,	NULL
MA	NULL
)	NULL
interfaced	NULL
with	NULL
an	NULL
IBM-PC	NULL
computer	NULL
.	NULL

The	NULL
surface	NULL
expression	NULL
of	NULL
CAMs	NULL
is	NULL
shown	NULL
as	NULL
mean	NULL
+	NULL
standard	NULL
deviation	NULL
(	NULL
SD	NULL
)	NULL
of	NULL
the	NULL
optical	NULL
density	NULL
(	NULL
OD	NULL
)	NULL
after	NULL
subtracting	NULL
the	NULL
blank	NULL
value	NULL
,	NULL
that	NULL
is	NULL
the	NULL
OD	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
primary	NULL
antibody	NULL
.	NULL

P	NULL
Labeling	NULL
of	NULL
HUVEC	NULL
and	NULL
immunoprecipitation	NULL
of	NULL
PECAM-1	NULL
.	NULL

HUVEC	NULL
grown	NULL
to	NULL
confluence	NULL
in	NULL
tissue	NULL
culture	NULL
dishes	NULL
(	NULL
100	NULL
X	NULL
15	NULL
mm	NULL
)	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
prewarmed	NULL
phosphate-free	NULL
RPMI-1640	NULL
(	NULL
GIBCO-BRL	NULL
)	NULL
and	NULL
radiolabeled	NULL
in	NULL
3	NULL
mL	NULL
of	NULL
phosphate-free	NULL
medium	NULL
containing	NULL
0.20	NULL
mCi	NULL
of	NULL
(	NULL
carrier-free	NULL
;	NULL
ICN	NULL
Biomedicals	NULL
,	NULL
Inc	NULL
,	NULL
Irvine	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
4	NULL
hours	NULL
at	NULL
37°C	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

The	NULL
monolayer	NULL
of	NULL
radiolabeled	NULL
HUVEC	NULL
was	NULL
washed	NULL
with	NULL
phosphate-free	NULL
medium	NULL
and	NULL
incubated	NULL
in	NULL
3	NULL
mL	NULL
of	NULL
the	NULL
same	NULL
medium	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
RBC	NULL
(	NULL
hematocrit	NULL
2	NULL
%	NULL
)	NULL
and	NULL
E-CM	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
intervals	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
incubation	NULL
,	NULL
the	NULL
medium	NULL
was	NULL
aspirated	NULL
and	NULL
cells	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
3	NULL
mL	NULL
of	NULL
ice-cold	NULL
PBS	NULL
.	NULL

Endothelial	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
1	NULL
mL	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
50	NULL
mmol/L	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
8.0	NULL
;	NULL
150	NULL
mmol/L	NULL
NaCl	NULL
;	NULL
0.1	NULL
%	NULL
SDS	NULL
;	NULL
50	NULL
mmol/L	NULL
NaF	NULL
,	NULL
10	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
;	NULL
0.1	NULL
mmol/L	NULL
DTT	NULL
;	NULL
0.5	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
;	NULL
2	NULL
mmol/L	NULL
sodium	NULL
orthovana-date	NULL
;	NULL
100	NULL
ug/mL	NULL
PMSF	NULL
;	NULL
1	NULL
ug/mL	NULL
pepstatin	NULL
;	NULL
and	NULL
1ug/mL	NULL
leupeptin	NULL
)	NULL
.	NULL

The	NULL
lysate	NULL
was	NULL
centrifuged	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
an	NULL
antibody	NULL
to	NULL
PECAM-1	NULL
(	NULL
as	NULL
ascites	NULL
fluid	NULL
from	NULL
clone	NULL
XVD	NULL
;	NULL
)	NULL
as	NULL
previously	NULL
de-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

SS	NULL
RBC-INDUCED	NULL
OXIDANT	NULL
STRESS	NULL
IN	NULL
ENDOTHELIUM	NULL
scribed	NULL
.	NULL
``	NULL

''	NULL
The	NULL
immunocomplex	NULL
was	NULL
collected	NULL
by	NULL
centrifugation	NULL
,	NULL
washed	NULL
with	NULL
lysis	NULL
buffer	NULL
,	NULL
and	NULL
the	NULL
sample	NULL
was	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
on	NULL
a	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
overnight	NULL
to	NULL
Kodak	NULL
XR-5	NULL
film	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
radioactivity	NULL
in	NULL
the	NULL
band	NULL
corresponding	NULL
to	NULL
PECAM-1	NULL
(	NULL
130	NULL
kD	NULL
)	NULL
was	NULL
quantitated	NULL
by	NULL
using	NULL
an	NULL
Ambis	NULL
radioactivity	NULL
gel	NULL
scanner	NULL
(	NULL
Model	NULL
101	NULL
;	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Fluorescent	NULL
labeling	NULL
of	NULL
HL-60	NULL
monocyte-like	NULL
cells	NULL
.	NULL

-	NULL
Vitamin	NULL
Dy	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
a	NULL
fluorescent	NULL
probe	NULL
,	NULL
CellTracker	NULL
Green	NULL
BODIPY	NULL
(	NULL
8-chloromethyl-4,4-difluoro-1,3,5,7-tetramethyl-4-bora-3a,4a-diazaindacene	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Molecular	NULL
Probes	NULL
Inc	NULL
,	NULL
Eugene	NULL
,	NULL
OR	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
medium	NULL
was	NULL
aspirated	NULL
from	NULL
Vitamin	NULL
Ds-differentiated	NULL
HL-60	NULL
cells	NULL
cultivated	NULL
in	NULL
tissue	NULL
culture	NULL
plates	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
medium	NULL
containing	NULL
fluorescent	NULL
probe	NULL
(	NULL
5	NULL
pmol/L	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
45	NULL
minutes	NULL
.	NULL

The	NULL
loading	NULL
solution	NULL
was	NULL
then	NULL
replaced	NULL
with	NULL
fresh	NULL
prewarmed	NULL
medium	NULL
and	NULL
the	NULL
cultures	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
30	NULL
minutes	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
fluorescently	NULL
labeled	NULL
HL-60	NULL
cells	NULL
were	NULL
used	NULL
for	NULL
a	NULL
transendothelial	NULL
migration	NULL
assay	NULL
.	NULL

Assay	NULL
for	NULL
transendothelial	NULL
migration	NULL
of	NULL
monocytes	NULL
.	NULL

-	NULL
HUVEC	NULL
monolayers	NULL
were	NULL
grown	NULL
to	NULL
confluence	NULL
on	NULL
fibronectin-coated	NULL
porous	NULL
membranes	NULL
(	NULL
Biocoat	NULL
Cell	NULL
culture	NULL
inserts	NULL
,	NULL
3.0	NULL
micron	NULL
;	NULL
Collaborative	NULL
Biomedical	NULL
Products	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
for	NULL
5	NULL
to	NULL
6	NULL
days	NULL
as	NULL
described	NULL
.	NULL
``	NULL

Transendothelial	NULL
resistance	NULL
was	NULL
measured	NULL
daily	NULL
on	NULL
the	NULL
filters	NULL
with	NULL
sterilized	NULL
electrodes	NULL
using	NULL
an	NULL
EVOM	NULL
voltohmmeter	NULL
(	NULL
World	NULL
Precision	NULL
Instruments	NULL
,	NULL
Sarasota	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

At	NULL
day	NULL
5	NULL
to	NULL
6	NULL
,	NULL
HUVEC	NULL
monolayer	NULL
exhibited	NULL
total	NULL
electrical	NULL
resistance	NULL
(	NULL
endothelial	NULL
cell	NULL
monolayer	NULL
with	NULL
filter	NULL
)	NULL
of	NULL
58	NULL
+	NULL
8	NULL
ohms.cm	NULL
>	NULL
(	NULL
n	NULL
=	NULL
13	NULL
)	NULL
with	NULL
net	NULL
transendothelial	NULL
electrical	NULL
resistance	NULL
of	NULL
30	NULL
+	NULL
4	NULL
ohms.cm	NULL
``	NULL
and	NULL
were	NULL
used	NULL
at	NULL
that	NULL
time	NULL
for	NULL
migration	NULL
studies	NULL
.	NULL

The	NULL
values	NULL
for	NULL
transendothelial	NULL
electrical	NULL
resistance	NULL
for	NULL
HUVEC	NULL
cultivated	NULL
on	NULL
fibronectin-coated	NULL
porous	NULL
membranes	NULL
are	NULL
similar	NULL
to	NULL
literature	NULL
values	NULL
of	NULL
28	NULL
+	NULL
11	NULL
ohms.cm	NULL
>	NULL
for	NULL
HUVEC	NULL
monolayer	NULL
cultured	NULL
on	NULL
polyethylene	NULL
terephthalate	NULL
micropore	NULL
membranes	NULL
.	NULL
``	NULL

Confluent	NULL
monolayers	NULL
of	NULL
HUVEC	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
in	NULL
duplicate	NULL
with	NULL
aliquots	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
well	NULL
)	NULL
of	NULL
fluorescently	NULL
labeled	NULL
vitamin	NULL
D	NULL
;	NULL
-differentiated	NULL
HL-60	NULL
cells	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
RBC	NULL
(	NULL
hematocrit	NULL
2	NULL
%	NULL
)	NULL
,	NULL
containing	NULL
E-CM	NULL
for	NULL
time	NULL
periods	NULL
ranging	NULL
from	NULL
30	NULL
minutes	NULL
to	NULL
4	NULL
hours	NULL
.	NULL

The	NULL
lower	NULL
compartment	NULL
of	NULL
the	NULL
Transwell	NULL
chamber	NULL
contained	NULL
1	NULL
mL	NULL
of	NULL
RPMI-1640	NULL
,	NULL
whereas	NULL
the	NULL
upper	NULL
compartment	NULL
contained	NULL
0.5	NULL
mL	NULL
of	NULL
the	NULL
same	NULL
medium	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
HL-60	NULL
cells	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
time	NULL
points	NULL
,	NULL
aliquots	NULL
of	NULL
50	NULL
uL	NULL
were	NULL
removed	NULL
from	NULL
the	NULL
bottom	NULL
compartment	NULL
of	NULL
the	NULL
well	NULL
.	NULL

Cells	NULL
were	NULL
counted	NULL
on	NULL
the	NULL
coverslip	NULL
using	NULL
a	NULL
fluorescence	NULL
microscope	NULL
(	NULL
Olympus	NULL
IMT	NULL
2	NULL
attached	NULL
with	NULL
a	NULL
10	NULL
X	NULL
10	NULL
mm	NULL
grid	NULL
in	NULL
the	NULL
eyepiece	NULL
;	NULL
Olympus	NULL
Optical	NULL
Co	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Only	NULL
those	NULL
cells	NULL
that	NULL
were	NULL
viable	NULL
were	NULL
counted	NULL
by	NULL
this	NULL
procedure	NULL
(	NULL
dead	NULL
cells	NULL
release	NULL
the	NULL
fluorescent	NULL
marker	NULL
)	NULL
.	NULL

To	NULL
keep	NULL
the	NULL
volume	NULL
constant	NULL
in	NULL
the	NULL
lower	NULL
compartment	NULL
,	NULL
an	NULL
equal	NULL
amount	NULL
(	NULL
50	NULL
uL	NULL
)	NULL
of	NULL
medium	NULL
was	NULL
added	NULL
at	NULL
each	NULL
removal	NULL
of	NULL
monocytes	NULL
.	NULL

In	NULL
inhibition	NULL
experiments	NULL
,	NULL
antibodies	NULL
and	NULL
inhibitors	NULL
were	NULL
added	NULL
30	NULL
minutes	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
RBC	NULL
to	NULL
HUVEC	NULL
.	NULL

Data	NULL
analysis	NULL
.	NULL

-	NULL
All	NULL
experiments	NULL
on	NULL
cell-adhesion	NULL
molecule	NULL
expression	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
with	NULL
at	NULL
least	NULL
three	NULL
different	NULL
batches	NULL
of	NULL
endothelial	NULL
cell	NULL
preparations	NULL
.	NULL

Each	NULL
treatment	NULL
(	NULL
incubation	NULL
with	NULL
RBC	NULL
)	NULL
was	NULL
compared	NULL
with	NULL
its	NULL
respective	NULL
control	NULL
(	NULL
untreated	NULL
)	NULL
.	NULL

The	NULL
results	NULL
for	NULL
the	NULL
incorporation	NULL
of	NULL
°P	NULL
into	NULL
PECAM-1	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
percent	NULL
of	NULL
control	NULL
and	NULL
are	NULL
mean	NULL
+	NULL
SD	NULL
.	NULL

The	NULL
statistical	NULL
significance	NULL
of	NULL
difference	NULL
in	NULL
a	NULL
treatment	NULL
series	NULL
was	NULL
determined	NULL
by	NULL
analysis	NULL
of	NULL
variance	NULL
.	NULL

Individual	NULL
treatments	NULL
in	NULL
the	NULL
experimental	NULL
series	NULL
were	NULL
compared	NULL
with	NULL
their	NULL
controls	NULL
using	NULL
Dunnet	NULL
's	NULL
test	NULL
.	NULL

Statistical	NULL
analyses	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
Instat-2	NULL
software	NULL
program	NULL
(	NULL
GraphPad	NULL
Software	NULL
)	NULL
.	NULL

RESULTS	NULL
Effect	NULL
of	NULL
SS	NULL
RBC	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
oxidant	NULL
stress	NULL
in	NULL
HUVEC	NULL
.	NULL

-	NULL
We	NULL
determined	NULL
whether	NULL
the	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
could	NULL
induce	NULL
oxidant	NULL
stress	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
1	NULL
,	NULL
SS	NULL
RBC	NULL
were	NULL
3927	NULL
2.5	NULL
times	NULL
more	NULL
adherent	NULL
to	NULL
the	NULL
endothelial	NULL
cells	NULL
than	NULL
were	NULL
those	NULL
from	NULL
normal	NULL
individuals	NULL
.	NULL

Additionally	NULL
,	NULL
SS	NULL
RBC	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
multimers	NULL
of	NULL
vWf	NULL
(	NULL
conditioned	NULL
medium	NULL
from	NULL
endothelial	NULL
cells	NULL
,	NULL
E-CM	NULL
)	NULL
exhibited	NULL
threefold	NULL
more	NULL
adherence	NULL
than	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
E-CM	NULL
,	NULL
as	NULL
has	NULL
been	NULL
previously	NULL
observed	NULL
.	NULL
``	NULL

The	NULL
augmented	NULL
adherence	NULL
of	NULL
SS	NULL
RBC	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
multimers	NULL
of	NULL
vWf	NULL
(	NULL
E-CM	NULL
)	NULL
was	NULL
observed	NULL
to	NULL
be	NULL
optimal	NULL
with	NULL
100	NULL
ug	NULL
protein/mL	NULL
of	NULL
E-CM	NULL
and	NULL
inhibited	NULL
by	NULL
antibody	NULL
to	NULL
vWf	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
1	NULL
,	NULL
incubation	NULL
of	NULL
SS	NULL
RBC	NULL
at	NULL
a	NULL
concentration	NULL
approximating	NULL
a	NULL
hematocrit	NULL
of	NULL
2	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
with	NULL
HUVEC	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
E-CM	NULL
led	NULL
to	NULL
approximately	NULL
three-and	NULL
fivefold	NULL
increased	NULL
formation	NULL
of	NULL
TBARS	NULL
,	NULL
respectively	NULL
,	NULL
relative	NULL
to	NULL
HUVEC	NULL
coincubated	NULL
with	NULL
normal	NULL
(	NULL
AA	NULL
)	NULL
RBC	NULL
with	NULL
and	NULL
without	NULL
E-CM	NULL
.	NULL

The	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
to	NULL
endothelial	NULL
cells	NULL
mediated	NULL
by	NULL
multimeric	NULL
vWF	NULL
(	NULL
E-CM	NULL
)	NULL
appears	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
oxidant	NULL
stress	NULL
(	NULL
lipid	NULL
peroxide	NULL
)	NULL
induction	NULL
because	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
peptide	NULL
Lys-Tyr-Arg-Gly-Asp-Ser	NULL
(	NULL
KYRGDS	NULL
)	NULL
containing	NULL
the	NULL
arginine-glycine-aspartic	NULL
acid	NULL
(	NULL
RGD	NULL
)	NULL
sequence	NULL
motif	NULL
,	NULL
which	NULL
prevents	NULL
multimeric	NULL
vWf-mediated	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
to	NULL
HUVEC	NULL
,	NULL
``	NULL
>	NULL
>	NULL
°	NULL
completely	NULL
inhibited	NULL
the	NULL
formation	NULL
of	NULL
TBARS	NULL
,	NULL
over	NULL
and	NULL
above	NULL
that	NULL
of	NULL
SS	NULL
RBC	NULL
alone	NULL
,	NULL
whereas	NULL
a	NULL
variant	NULL
peptide	NULL
Ala-Gly-Asp-Val	NULL
(	NULL
AGDV	NULL
)	NULL
did	NULL
not	NULL
prevent	NULL
either	NULL
the	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
or	NULL
the	NULL
formation	NULL
of	NULL
TBARS	NULL
.	NULL

Both	NULL
catalase	NULL
(	NULL
200	NULL
U/mL	NULL
)	NULL
and	NULL
superoxide	NULL
dismutase	NULL
(	NULL
200	NULL
U/mL	NULL
)	NULL
together	NULL
,	NULL
scavengers	NULL
of	NULL
free	NULL
radicals	NULL
,	NULL
``	NULL
``	NULL
completely	NULL
abrogated	NULL
SS	NULL
RBC	NULL
+	NULL
E-CM-induced	NULL
TBARS	NULL
formation	NULL
in	NULL
HUVEC	NULL
,	NULL
relative	NULL
to	NULL
HUVEC	NULL
incubated	NULL
with	NULL
SS	NULL
RBC	NULL
alone	NULL
.	NULL

Moreover	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
superoxide	NULL
dismutase	NULL
(	NULL
SOD	NULL
)	NULL
and	NULL
catalase	NULL
the	NULL
formation	NULL
of	NULL
lipid	NULL
peroxides	NULL
(	NULL
TBARS	NULL
)	NULL
in	NULL
HUVEC	NULL
was	NULL
observed	NULL
to	NULL
be	NULL
50	NULL
%	NULL
reduced	NULL
below	NULL
the	NULL
level	NULL
of	NULL
HUVEC	NULL
incubated	NULL
with	NULL
SS	NULL
RBC	NULL
alone	NULL
.	NULL

It	NULL
is	NULL
pertinent	NULL
to	NULL
note	NULL
that	NULL
incubation	NULL
of	NULL
SS	NULL
RBC	NULL
(	NULL
2	NULL
%	NULL
Het	NULL
)	NULL
alone	NULL
for	NULL
2	NULL
to	NULL
4	NULL
hours	NULL
did	NULL
not	NULL
show	NULL
the	NULL
formation	NULL
of	NULL
TBARS	NULL
because	NULL
its	NULL
formation	NULL
was	NULL
below	NULL
the	NULL
detection	NULL
limit	NULL
of	NULL
the	NULL
assay	NULL
.	NULL

However	NULL
,	NULL
at	NULL
a	NULL
higher	NULL
concentration	NULL
(	NULL
10	NULL
%	NULL
)	NULL
of	NULL
SS	NULL
RBC	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
MDA	NULL
formed	NULL
by	NULL
SS	NULL
RBC	NULL
alone	NULL
was	NULL
8.78	NULL
+	NULL
0.62	NULL
nmole	NULL
MDA/g	NULL
hemoglobin	NULL
(	NULL
n	NULL
=	NULL
4	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
studies	NULL
.	NULL
``	NULL

Overall	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
to	NULL
endothelial	NULL
cells	NULL
,	NULL
mediated	NULL
by	NULL
multimers	NULL
of	NULL
vWf	NULL
(	NULL
E-CM	NULL
)	NULL
,	NULL
generates	NULL
greater	NULL
amounts	NULL
(	NULL
approxi-mately	NULL
twofold	NULL
)	NULL
of	NULL
ROS	NULL
over	NULL
and	NULL
above	NULL
that	NULL
observed	NULL
with	NULL
SS	NULL
RBC	NULL
alone	NULL
interaction	NULL
with	NULL
endothelial	NULL
cells	NULL
.	NULL

SS	NULL
RBC-induced	NULL
activation	NULL
of	NULL
NF-kB	NULL
activity	NULL
in	NULL
HUVEC	NULL
.	NULL

We	NULL
measured	NULL
,	NULL
in	NULL
HUVEC	NULL
nuclear	NULL
extracts	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
,	NULL
another	NULL
index	NULL
of	NULL
cellular	NULL
oxidant	NULL
stress	NULL
.	NULL

!	NULL
``	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
1	NULL
,	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
HUVEC	NULL
that	NULL
had	NULL
been	NULL
incubated	NULL
with	NULL
SS	NULL
RBC	NULL
and	NULL
E-CM	NULL
,	NULL
showed	NULL
a	NULL
time-dependent	NULL
increase	NULL
in	NULL
NF-kB	NULL
activity	NULL
.	NULL

The	NULL
maximal	NULL
activation	NULL
of	NULL
NF-kB	NULL
activity	NULL
occurred	NULL
at	NULL
1	NULL
hour	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
decrease	NULL
at	NULL
2	NULL
hours	NULL
and	NULL
4	NULL
hours	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
1	NULL
,	NULL
gel-shift	NULL
binding	NULL
assays	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
excess	NULL
competing	NULL
oligonucleotide	NULL
resulted	NULL
in	NULL
a	NULL
decrease	NULL
in	NULL
NF-kB	NULL
activity	NULL
,	NULL
indicating	NULL
specificity	NULL
of	NULL
interaction	NULL
of	NULL
DNA	NULL
binding	NULL
proteins	NULL
with	NULL
an	NULL
NF-kB	NULL
nucleotide	NULL
sequence	NULL
.	NULL

There	NULL
was	NULL
minimal	NULL
activation	NULL
of	NULL
NF-kB	NULL
activity	NULL
when	NULL
HUVEC	NULL
were	NULL
incubated	NULL
with	NULL
AA	NULL
RBC	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
E-CM	NULL
at	NULL
the	NULL
1-hour	NULL
time	NULL
point	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
,	NULL
the	NULL
optimal	NULL
time	NULL
period	NULL
for	NULL
activation	NULL
of	NULL
NF-kB	NULL
with	NULL
SS	NULL
RBC	NULL
plus	NULL
E-CM	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
2	NULL
,	NULL
incubation	NULL
of	NULL
normal	NULL
red	NULL
blood	NULL
cells	NULL
(	NULL
AA	NULL
RBC	NULL
)	NULL
with	NULL
HUVEC	NULL
for	NULL
a	NULL
prolonged	NULL
time	NULL
(	NULL
4	NULL
hours	NULL
)	NULL
with	NULL
or	NULL
without	NULL
E-CM	NULL
did	NULL
not	NULL
significantly	NULL
increase	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3928	NULL
Inhibitor	NULL
-	NULL
-	NULL
Competing	NULL
Oligo	NULL
-	NULL
-o	NULL
o	NULL
E-CM	NULL
+	NULL
-	NULL
+	NULL
RBC	NULL
AA	NULL
SS	NULL
SS	NULL
SS	NULL
Time	NULL
(	NULL
hr	NULL
)	NULL
1	NULL
0	NULL
_-	NULL
0.5	NULL
NF-kB	NULL
>	NULL
_	NULL
__	NULL
Fig	NULL
1	NULL
.	NULL

SULTANA	NULL
ET	NULL
AL	NULL
5	NULL
®	NULL
-_	NULL
§	NULL
A	NULL
_	NULL
B	NULL
a	NULL
O	NULL
<	NULL
3	NULL
c	NULL
r	NULL
A	NULL
g	NULL
©	NULL
°	NULL
y	NULL
O	NULL
-	NULL
?	NULL

a	NULL
-	NULL
-	NULL
O	NULL
x	NULL
OIC	NULL
A	NULL
-	NULL
_	NULL
+	NULL
_	NULL
-	NULL
-	NULL
+	NULL
Fo	NULL
oto	NULL
o	NULL
toot	NULL
oto	NULL
o+	NULL
SS	NULL
SS	NULL
SS	NULL
SS	NULL
SS	NULL
SS	NULL
SS	NULL
2	NULL
-	NULL
4	NULL
1	NULL
1	NULL
10	NULL
1	NULL
1	NULL
po	NULL
Effect	NULL
of	NULL
incubation	NULL
of	NULL
RBC	NULL
and	NULL
inhibitors	NULL
on	NULL
NF-kB	NULL
activity	NULL
in	NULL
HUVEC	NULL
nuclear	NULL
extracts	NULL
by	NULL
gel-shift	NULL
assay	NULL
.	NULL

HUVEC	NULL
were	NULL
incubated	NULL
with	NULL
RBC	NULL
(	NULL
2	NULL
%	NULL
Hct	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
E-CM	NULL
(	NULL
100	NULL
pg/mL	NULL
)	NULL
for	NULL
60	NULL
minutes	NULL
,	NULL
unless	NULL
otherwise	NULL
indicated	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
inhibitors	NULL
(	NULL
genistein	NULL
,	NULL
25	NULL
g/mL	NULL
;	NULL
KYRGDS	NULL
,	NULL
100	NULL
pmol/L	NULL
;	NULL
HFPA	NULL
,	NULL
10	NULL
pmol/L	NULL
;	NULL
and	NULL
probucol	NULL
,	NULL
50	NULL
wmol/L	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
incubated	NULL
with	NULL
a	NULL
double-stranded	NULL
``	NULL
P-labeled	NULL
NF-kB	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
excess	NULL
cold	NULL
competitor	NULL
oligonucleotide	NULL
was	NULL
added	NULL
to	NULL
the	NULL
nuclear	NULL
extracts	NULL
and	NULL
incubated	NULL
for	NULL
10	NULL
minutes	NULL
before	NULL
addition	NULL
of	NULL
radiolabeled	NULL
DNA	NULL
probe	NULL
.	NULL

The	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

NE-kB	NULL
activity	NULL
over	NULL
that	NULL
of	NULL
untreated	NULL
HUVEC	NULL
.	NULL

Furthermore	NULL
,	NULL
SS	NULL
RBC	NULL
incubation	NULL
with	NULL
HUVEC	NULL
alone	NULL
for	NULL
1	NULL
hour	NULL
augmented	NULL
by	NULL
twofold	NULL
activation	NULL
of	NULL
NF-kB	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
incubation	NULL
of	NULL
SS	NULL
RBC	NULL
with	NULL
HUVEC	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
E-CM	NULL
increased	NULL
by	NULL
twofold	NULL
the	NULL
NF-kB	NULL
activity	NULL
over	NULL
and	NULL
above	NULL
that	NULL
of	NULL
HUVEC	NULL
incubated	NULL
with	NULL
SS	NULL
RBC	NULL
alone	NULL
.	NULL

This	NULL
data	NULL
is	NULL
qualitatively	NULL
similar	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
TBARS	NULL
in	NULL
HUVEC	NULL
by	NULL
SS	NULL
RBC	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
E-CM	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
2	NULL
,	NULL
incubation	NULL
of	NULL
HUVEC	NULL
with	NULL
E-CM	NULL
alone	NULL
did	NULL
not	NULL
affect	NULL
basal	NULL
NE-kB	NULL
activity	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
1	NULL
,	NULL
SS	NULL
RBC	NULL
+	NULL
E-CM	NULL
induced	NULL
activation	NULL
of	NULL
NE-kB	NULL
was	NULL
inhibited	NULL
by	NULL
a	NULL
tyrosine	NULL
kinse	NULL
inhibitor	NULL
,	NULL
genistein	NULL
``	NULL
;	NULL
and	NULL
by	NULL
antioxidant	NULL
,	NULL
probucol	NULL
.	NULL
``	NULL

Other	NULL
antioxidants	NULL
,	NULL
pyrroli-dinedithiocarbamate	NULL
(	NULL
PDTC	NULL
)	NULL
and	NULL
vitamin	NULL
E	NULL
,	NULL
also	NULL
inhibited	NULL
NE-kB	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
NE-kB	NULL
in	NULL
HUVEC	NULL
nuclear	NULL
extracts	NULL
induced	NULL
by	NULL
SS	NULL
RBC	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
E-CM	NULL
was	NULL
inhibited	NULL
when	NULL
HUVEC	NULL
were	NULL
preincu-	NULL
bated	NULL
with	NULL
the	NULL
synthetic	NULL
peptide	NULL
KYRGDS	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
observed	NULL
that	NULL
tert-butylhydroperoxide	NULL
,	NULL
an	NULL
inducer	NULL
of	NULL
oxidant	NULL
stress	NULL
,	NULL
causes	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NE-kB	NULL
as	NULL
a	NULL
result	NULL
of	NULL
activation	NULL
of	NULL
p21	NULL
``	NULL
**	NULL
4	NULL
;	NULL
thus	NULL
we	NULL
examined	NULL
whether	NULL
the	NULL
NF-kB	NULL
activation	NULL
that	NULL
was	NULL
induced	NULL
by	NULL
SS	NULL
RBC	NULL
could	NULL
be	NULL
blocked	NULL
by	NULL
an	NULL
inhibitor	NULL
of	NULL
p21'*	NULL
activity	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
1	NULL
,	NULL
treatment	NULL
of	NULL
HUVEC	NULL
with	NULL
a	NULL
p21	NULL
``	NULL
farnesyltransferase	NULL
inhibitor	NULL
``	NULL
(	NULL
«	NULL
-hydroxyfarnesylphosphonic	NULL
acid	NULL
,	NULL
HFPA	NULL
)	NULL
,	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
SS	NULL
RBC	NULL
+	NULL
E-CM	NULL
inhibited	NULL
NF-kB	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
interaction	NULL
of	NULL
SS	NULL
RBC	NULL
with	NULL
HUVEC	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
multimers	NULL
of	NULL
vWf	NULL
(	NULL
E-CM	NULL
)	NULL
,	NULL
causes	NULL
a	NULL
greater	NULL
activation	NULL
of	NULL
NF-kB	NULL
over	NULL
and	NULL
above	NULL
that	NULL
observed	NULL
with	NULL
SS	NULL
RBC	NULL
alone	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
chose	NULL
to	NULL
study	NULL
the	NULL
effect	NULL
of	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
,	NULL
mediated	NULL
by	NULL
multimers	NULL
of	NULL
vWf	NULL
(	NULL
E-CM	NULL
)	NULL
,	NULL
on	NULL
the	NULL
cellular	NULL
signaling	NULL
in	NULL
HUVEC	NULL
leading	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
CAMs	NULL
and	NULL
migration	NULL
of	NULL
monocytes	NULL
across	NULL
the	NULL
endothelial	NULL
cell	NULL
monolayer	NULL
in	NULL
the	NULL
following	NULL
studies	NULL
.	NULL

E-CM	NULL
$	NULL
8	NULL
RBC	NULL
(	NULL
Thr	NULL
)	NULL
+E-CM+Oligo	NULL
SS	NULL
RBC	NULL
(	NULL
thr	NULL
)	NULL
+E-CM	NULL
§§	NULL
RBC	NULL
(	NULL
1	NULL
hr	NULL
)	NULL
AA	NULL
RBC	NULL
(	NULL
4hr	NULL
)	NULL
+E-CM	NULL
AA	NULL
RBC	NULL
(	NULL
4	NULL
hr	NULL
)	NULL
AA	NULL
RBC	NULL
(	NULL
1	NULL
hr	NULL
)	NULL
None	NULL
200	NULL
300	NULL
Relative	NULL
NF-kB	NULL
activity	NULL
(	NULL
%	NULL
of	NULL
control	NULL
)	NULL
Fig	NULL
2	NULL
.	NULL

Relative	NULL
NF-kB	NULL
activation	NULL
in	NULL
HUVEC	NULL
in	NULL
response	NULL
to	NULL
interaction	NULL
of	NULL
RBC	NULL
.	NULL

HUVEC	NULL
were	NULL
incubated	NULL
with	NULL
either	NULL
AA	NULL
RBC	NULL
(	NULL
n	NULL
=	NULL
3	NULL
;	NULL
two	NULL
different	NULL
donors	NULL
)	NULL
for	NULL
1	NULL
hour	NULL
and	NULL
4	NULL
hours	NULL
or	NULL
with	NULL
SS	NULL
RBC	NULL
(	NULL
n	NULL
=	NULL
4	NULL
;	NULL
three	NULL
different	NULL
donors	NULL
and	NULL
one	NULL
replicate	NULL
)	NULL
for	NULL
1	NULL
hour	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
E-CM	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
probed	NULL
for	NULL
NF-kB	NULL
activity	NULL
.	NULL

The	NULL
NF-kB	NULL
activity	NULL
in	NULL
the	NULL
gel	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
was	NULL
quantified	NULL
by	NULL
densitometric	NULL
scan	NULL
of	NULL
the	NULL
autoradiograph	NULL
by	NULL
Alpha	NULL
Image	NULL
2000	NULL
Documentation	NULL
and	NULL
Analysis	NULL
system	NULL
.	NULL

The	NULL
data	NULL
show	NULL
n	NULL
is	NULL
relative	NULL
change	NULL
in	NULL
NF-kB	NULL
activity	NULL
compared	NULL
to	NULL
untreated	NULL
HUVEC	NULL
.	NULL

NF-kB	NULL
activity	NULL
increased	NULL
to	NULL
365	NULL
%	NULL
+	NULL
34	NULL
%	NULL
(	NULL
range	NULL
,	NULL
320	NULL
%	NULL
to	NULL
425	NULL
%	NULL
)	NULL
on	NULL
400	NULL
incubation	NULL
of	NULL
HUVEC	NULL
with	NULL
SS	NULL
RBC	NULL
and	NULL
E-CM	NULL
.	NULL

Replicate	NULL
of	NULL
the	NULL
same	NULL
donor	NULL
sample	NULL
showed	NULL
less	NULL
than	NULL
10	NULL
%	NULL
variation	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

SS	NULL
RBC-INDUCED	NULL
OXIDANT	NULL
STRESS	NULL
IN	NULL
ENDOTHELIUM	NULL
Adherence	NULL
of	NULL
SS	NULL
RBC	NULL
to	NULL
HUVEC	NULL
leads	NULL
to	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
adhesion	NULL
molecules	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
3A	NULL
,	NULL
incubation	NULL
of	NULL
SS	NULL
RBC	NULL
(	NULL
2	NULL
%	NULL
hematocrit	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
vWf	NULL
(	NULL
E-CM	NULL
)	NULL
,	NULL
with	NULL
HUVEC	NULL
resulted	NULL
in	NULL
a	NULL
time-dependent	NULL
increase	NULL
in	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
ICAM-1	NULL
,	NULL
E-selectin	NULL
,	NULL
and	NULL
VCAM-1	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
ELISA	NULL
.	NULL

The	NULL
surface	NULL
expression	NULL
of	NULL
ICAM-1	NULL
continued	NULL
to	NULL
increase	NULL
above	NULL
basal	NULL
level	NULL
(	NULL
untreated	NULL
HUVEC	NULL
)	NULL
at	NULL
12	NULL
hours	NULL
and	NULL
remained	NULL
unchanged	NULL
up	NULL
to	NULL
24	NULL
hours	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
VCAM-1	NULL
was	NULL
also	NULL
optimal	NULL
at	NULL
12	NULL
hours	NULL
.	NULL

However	NULL
,	NULL
E-selectin	NULL
surface	NULL
expression	NULL
,	NULL
though	NULL
it	NULL
increased	NULL
up	NULL
to	NULL
8	NULL
hours	NULL
in	NULL
response	NULL
to	NULL
incubation	NULL
with	NULL
SS	NULL
RBC	NULL
,	NULL
then	NULL
declined	NULL
to	NULL
almost	NULL
basal	NULL
level	NULL
by	NULL
12	NULL
to	NULL
24	NULL
hours	NULL
.	NULL

Moreover	NULL
,	NULL
there	NULL
was	NULL
no	NULL
affect	NULL
on	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
constitutively	NULL
expressed	NULL
ICAM-2	NULL
by	NULL
SS	NULL
RBC	NULL
and	NULL
E-CM	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
effect	NULL
observed	NULL
was	NULL
specific	NULL
for	NULL
SS	NULL
RBC	NULL
(	NULL
Hb	NULL
SS	NULL
)	NULL
,	NULL
HUVEC	NULL
were	NULL
incubated	NULL
with	NULL
normal	NULL
RBC	NULL
(	NULL
Hb	NULL
AA	NULL
)	NULL
and	NULL
SC	NULL
I	NULL
>	NULL
0.7	NULL
-__	NULL
-+-	NULL
ICAM	NULL
_	NULL
os	NULL
-	NULL
-a-	NULL
E-selectin	NULL
--	NULL
VCAMA	NULL
0.6	NULL
0.4	NULL
-I	NULL
0.3	NULL
ession	NULL
of	NULL
CAMs	NULL
Exgr	NULL
(	NULL
O.D	NULL
.	NULL

at	NULL
405	NULL
nm	NULL
)	NULL
0.2	NULL
or	NULL
f/	NULL
0.0	NULL
t	NULL
Time	NULL
(	NULL
hr	NULL
)	NULL
LPS	NULL
polymxyin	NULL
B	NULL
AGDV	NULL
+	NULL
SS	NULL
RBC	NULL
+	NULL
E-CM	NULL
KYRGOS	NULL
SS	NULL
RBC+E-CM	NULL
E-CM	NULL
|	NULL
None	NULL
~E.4	NULL
I	NULL
``	NULL
I	NULL
``	NULL
I	NULL
``	NULL
I	NULL
``	NULL
I	NULL
0.0	NULL
0.1	NULL
0.2	NULL
0.3	NULL
0.4	NULL
0.5	NULL
Expression	NULL
of	NULL
VCAM-1	NULL
(	NULL
O.D	NULL
.	NULL

at	NULL
405	NULL
nm	NULL
)	NULL
3929	NULL
trait	NULL
RBC	NULL
(	NULL
Hb	NULL
AS	NULL
)	NULL
under	NULL
identical	NULL
conditions	NULL
and	NULL
assayed	NULL
for	NULL
CAMs	NULL
expression	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
3B	NULL
,	NULL
there	NULL
was	NULL
no	NULL
significant	NULL
difference	NULL
in	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
CAMs	NULL
in	NULL
response	NULL
to	NULL
the	NULL
interaction	NULL
of	NULL
AA	NULL
and	NULL
AS	NULL
RBC	NULL
with	NULL
endothelial	NULL
cells	NULL
compared	NULL
with	NULL
untreated	NULL
ECs	NULL
.	NULL

Does	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
or	NULL
soluble	NULL
factor	NULL
released	NULL
from	NULL
SS	NULL
RBC	NULL
mediate	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
CAMs	NULL
?	NULL

-	NULL
As	NULL
shown	NULL
in	NULL
Fig	NULL
3C	NULL
,	NULL
E-CM	NULL
alone	NULL
(	NULL
vWf	NULL
)	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
SS	NULL
RBC	NULL
,	NULL
did	NULL
not	NULL
induce	NULL
VCAM-1	NULL
surface	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
E-CM	NULL
induced	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
VCAM-1	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SS	NULL
RBC	NULL
.	NULL

Moreover	NULL
,	NULL
addition	NULL
of	NULL
the	NULL
KYRGDS	NULL
peptide	NULL
(	NULL
100	NULL
umol/L	NULL
)	NULL
,	NULL
which	NULL
blocks	NULL
vWf-mediated	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
,	NULL
``	NULL
reduced	NULL
by	NULL
approximately	NULL
50	NULL
%	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
VCAM-1	NULL
,	NULL
whereas	NULL
the	NULL
variant-peptide	NULL
AGDV	NULL
failed	NULL
to	NULL
inhibit	NULL
VCAM-1	NULL
expression	NULL
induced	NULL
by	NULL
SS	NULL
RBC	NULL
and	NULL
E-CM	NULL
.	NULL

The	NULL
VCAM-1	NULL
expression	NULL
,	NULL
which	NULL
is	NULL
not	NULL
inhibitable	NULL
by	NULL
RGD	NULL
peptide	NULL
,	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
None	NULL
AA	NULL
RBC+E-CM	NULL
AS	NULL
RBC+E-CM	NULL
88	NULL
RBC+E-CM	NULL
@	NULL
0	NULL
g	NULL
®	NULL
Expression	NULL
of	NULL
adhesion	NULL
molecules	NULL
(	NULL
O.D	NULL
.	NULL

at	NULL
405	NULL
nm	NULL
)	NULL
ICAM-1	NULL
sso	NULL
-	NULL
GSH-EE	NULL
b	NULL
SOD+Catalase	NULL
—f_~l	NULL
Catalase	NULL
4-soo	NULL
--	NULL
-t-	NULL
-	NULL
:	NULL
Vitamin	NULL
E	NULL
+	NULL
S	NULL
$	NULL
RBC	NULL
+	NULL
E-CM	NULL
Probucol	NULL
$	NULL
8	NULL
RBC+E-CM	NULL
88	NULL
RBC	NULL
None	NULL
0.0	NULL
0.4	NULL
0.2	NULL
0.3	NULL
0.4	NULL
0.6	NULL
Expression	NULL
of	NULL
VCAM-1	NULL
(	NULL
O.D	NULL
.	NULL

at	NULL
405	NULL
nm	NULL
)	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
Cell	NULL
adhesion	NULL
molecule	NULL
expression	NULL
in	NULL
HUVEC	NULL
in	NULL
response	NULL
to	NULL
interaction	NULL
with	NULL
RBC	NULL
.	NULL

HUVEC	NULL
grow	NULL
n	NULL
to	NULL
confluence	NULL
in	NULL
24-well	NULL
plates	NULL
were	NULL
incubated	NULL
with	NULL
RBC	NULL
(	NULL
2	NULL
%	NULL
Hct	NULL
)	NULL
and	NULL
E-CM	NULL
(	NULL
100	NULL
pg/mL	NULL
)	NULL
for	NULL
4-hour	NULL
time	NULL
periods	NULL
,	NULL
unless	NULL
otherwise	NULL
indicated	NULL
.	NULL

ICAM-1	NULL
,	NULL
E-selectin	NULL
,	NULL
and	NULL
VCAM-1	NULL
expression	NULL
was	NULL
determined	NULL
by	NULL
ELISA	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Time	NULL
period	NULL
of	NULL
expression	NULL
of	NULL
CAMs	NULL
in	NULL
response	NULL
to	NULL
SS	NULL
RBC	NULL
plus	NULL
E-CM	NULL
;	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
OD	NULL
at	NULL
405	NULL
nm	NULL
of	NULL
triplicate	NULL
determinations	NULL
,	NULL
(	NULL
n	NULL
=	NULL
5	NULL
;	NULL
including	NULL
three	NULL
different	NULL
donors	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Effect	NULL
of	NULL
AA	NULL
RBC	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
,	NULL
AS	NULL
RBC	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
,	NULL
and	NULL
SS	NULL
RBC	NULL
(	NULL
n	NULL
=	NULL
6	NULL
;	NULL
including	NULL
four	NULL
different	NULL
donors	NULL
)	NULL
on	NULL
CAM	NULL
s	NULL
expression	NULL
at	NULL
4	NULL
hours	NULL
.	NULL

(	NULL
C	NULL
)	NULL
HUVEC	NULL
were	NULL
preincubated	NULL
for	NULL
30	NULL
minutes	NULL
with	NULL
peptides	NULL
(	NULL
KYRGDS	NULL
,	NULL
100	NULL
pmol/L	NULL
;	NULL
AGDYV	NULL
,	NULL
100	NULL
mol/L	NULL
)	NULL
and	NULL
polymyxin	NULL
sulfate	NULL
(	NULL
5	NULL
g/mL	NULL
)	NULL
before	NULL
incubation	NULL
with	NULL
SS	NULL
RBC	NULL
plus	NULL
E-CM	NULL
or	NULL
E-CM	NULL
(	NULL
100	NULL
g/mL	NULL
)	NULL
alone	NULL
for	NULL
4	NULL
hours	NULL
.	NULL

Incubation	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/	NULL
mL	NULL
)	NULL
was	NULL
performed	NULL
for	NULL
4	NULL
hours	NULL
.	NULL

(	NULL
D	NULL
)	NULL
HUVEC	NULL
were	NULL
preincubated	NULL
for	NULL
30	NULL
minutes	NULL
with	NULL
inhibitors	NULL
(	NULL
Probucol	NULL
,	NULL
50	NULL
wmol/	NULL
L	NULL
;	NULL
vitamin	NULL
E	NULL
,	NULL
25	NULL
pmol/L	NULL
;	NULL
SOD	NULL
,	NULL
(	NULL
200	NULL
U/mL	NULL
)	NULL
;	NULL
catalase	NULL
,	NULL
(	NULL
200	NULL
U/mL	NULL
)	NULL
;	NULL
GSH-EE	NULL
,	NULL
0.5	NULL
mmol/L	NULL
;	NULL
and	NULL
BSO	NULL
(	NULL
100	NULL
mol/L	NULL
)	NULL
before	NULL
incubation	NULL
with	NULL
SS	NULL
RBC	NULL
for	NULL
4	NULL
hours	NULL
,	NULL
followed	NULL
by	NULL
measurement	NULL
of	NULL
VCAM-1	NULL
expression	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3930	NULL
basal	NULL
level	NULL
of	NULL
oxidative	NULL
stress	NULL
generated	NULL
by	NULL
SS	NULL
RBC	NULL
alone	NULL
.	NULL
``	NULL

It	NULL
is	NULL
pertinent	NULL
to	NULL
note	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
synthetic	NULL
peptides	NULL
KYRGDS	NULL
and	NULL
AGDV	NULL
directly	NULL
to	NULL
HUVEC	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
SS	NULL
RBC	NULL
,	NULL
or	NULL
the	NULL
SS	NULL
RBC-conditioned	NULL
media	NULL
derived	NULL
from	NULL
the	NULL
incubation	NULL
of	NULL
1	NULL
mL	NULL
of	NULL
SS	NULL
RBC	NULL
(	NULL
20	NULL
%	NULL
Het	NULL
)	NULL
for	NULL
2	NULL
hours	NULL
,	NULL
failed	NULL
to	NULL
induce	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
VCAM-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
binding	NULL
of	NULL
small	NULL
peptide	NULL
ligands	NULL
or	NULL
components	NULL
present	NULL
in	NULL
the	NULL
medium	NULL
from	NULL
SS	NULL
RBC	NULL
to	NULL
the	NULL
putative	NULL
receptor	NULL
on	NULL
HUVEC	NULL
was	NULL
not	NULL
sufficient	NULL
to	NULL
induce	NULL
VCAM-1	NULL
expression	NULL
.	NULL

Treatment	NULL
of	NULL
HUVEC	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
exhibited	NULL
an	NULL
increase	NULL
in	NULL
VCAM-1	NULL
expression	NULL
over	NULL
and	NULL
above	NULL
the	NULL
level	NULL
observed	NULL
with	NULL
SS	NULL
RBC	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
E-CM	NULL
(	NULL
Fig	NULL
3C	NULL
)	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
VCAM-1	NULL
surface	NULL
expression	NULL
in	NULL
HUVEC	NULL
in	NULL
response	NULL
to	NULL
SS	NULL
RBC	NULL
E-CM	NULL
was	NULL
not	NULL
due	NULL
to	NULL
the	NULL
contaminating	NULL
effect	NULL
of	NULL
endotoxin	NULL
because	NULL
addition	NULL
of	NULL
polymyxin	NULL
B	NULL
(	NULL
5	NULL
ug/mL	NULL
)	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
endotoxin	NULL
,	NULL
did	NULL
not	NULL
reduce	NULL
VCAM-1	NULL
expression	NULL
(	NULL
Fig	NULL
3C	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
indicate	NULL
that	NULL
adherence	NULL
of	NULL
SS	NULL
RBC	NULL
mediated	NULL
by	NULL
vWf	NULL
augments	NULL
VCAM-1	NULL
expression	NULL
,	NULL
whereas	NULL
inhibition	NULL
of	NULL
adherence	NULL
by	NULL
RGD	NULL
peptide	NULL
reduces	NULL
the	NULL
VCAM-1	NULL
expression	NULL
.	NULL

Effect	NULL
of	NULL
antioxidants	NULL
on	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
VCAM-1	NULL
in	NULL
HUVEC	NULL
.	NULL

Because	NULL
probucol	NULL
inhibited	NULL
the	NULL
activation	NULL
of	NULL
NE-kB	NULL
activity	NULL
in	NULL
HUVEC	NULL
in	NULL
response	NULL
to	NULL
the	NULL
interaction	NULL
of	NULL
SS	NULL
RBC	NULL
+E-CM	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
antioxidants	NULL
on	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
VCAM-1	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
3D	NULL
,	NULL
pretreatment	NULL
of	NULL
HUVEC	NULL
with	NULL
the	NULL
antioxidants	NULL
probucol	NULL
(	NULL
50	NULL
umol/L	NULL
)	NULL
and	NULL
vitamin	NULL
E	NULL
(	NULL
25	NULL
umol/L	NULL
)	NULL
reduced	NULL
by	NULL
~90	NULL
%	NULL
VCAM-1	NULL
expression	NULL
induced	NULL
by	NULL
SS	NULL
RBC	NULL
plus	NULL
E-CM	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
SOD	NULL
and	NULL
catalase	NULL
,	NULL
completely	NULL
abrogated	NULL
the	NULL
VCAM-1	NULL
expression	NULL
over	NULL
and	NULL
above	NULL
that	NULL
observed	NULL
with	NULL
SS	NULL
RBC	NULL
alone	NULL
.	NULL

The	NULL
possibility	NULL
of	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
glutathione	NULL
redox	NULL
cycle	NULL
in	NULL
the	NULL
cellular	NULL
oxidant	NULL
stress	NULL
generated	NULL
by	NULL
the	NULL
interaction	NULL
of	NULL
SS	NULL
RBC	NULL
with	NULL
HUVEC	NULL
was	NULL
examined	NULL
through	NULL
the	NULL
use	NULL
of	NULL
agents	NULL
,	NULL
that	NULL
affect	NULL
intracellular	NULL
glutathione	NULL
levels	NULL
.	NULL
``	NULL

Elevation	NULL
of	NULL
intracellular	NULL
glutathione	NULL
(	NULL
GSH	NULL
)	NULL
levels	NULL
by	NULL
preincubation	NULL
of	NULL
HUVEC	NULL
with	NULL
the	NULL
cell-permeable	NULL
glutathione	NULL
ester	NULL
(	NULL
GSH-ethyl	NULL
ester	NULL
)	NULL
for	NULL
24	NULL
hours	NULL
completely	NULL
inhibited	NULL
SS	NULL
RBC	NULL
,	NULL
plus	NULL
E-CM	NULL
induced	NULL
VCAM-1	NULL
expression	NULL
(	NULL
Fig	NULL
3D	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
pretreatment	NULL
of	NULL
HUVEC	NULL
with	NULL
butathionine	NULL
sulfoximine	NULL
(	NULL
BSO	NULL
)	NULL
,	NULL
an	NULL
agent	NULL
that	NULL
prevents	NULL
GSH	NULL
synthesis	NULL
,	NULL
augmented	NULL
VCAM-1	NULL
expression	NULL
by	NULL
~40	NULL
%	NULL
over	NULL
and	NULL
above	NULL
that	NULL
observed	NULL
with	NULL
SS	NULL
RBC	NULL
plus	NULL
E-CM	NULL
(	NULL
Fig	NULL
3D	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
SS	NULL
RBC	NULL
-induced	NULL
oxidant	NULL
stress	NULL
on	NULL
the	NULL
transendothelial	NULL
migration	NULL
of	NULL
monocytes	NULL
.	NULL

In	NULL
our	NULL
recent	NULL
studies	NULL
,	NULL
``	NULL
we	NULL
observed	NULL
that	NULL
oxidant	NULL
stress	NULL
induced	NULL
by	NULL
tert-butylhydroperoxide	NULL
promoted	NULL
the	NULL
transendothelial	NULL
migration	NULL
of	NULL
monocytes	NULL
;	NULL
thus	NULL
we	NULL
examined	NULL
whether	NULL
ROS	NULL
generated	NULL
by	NULL
HUVEC	NULL
in	NULL
response	NULL
to	NULL
the	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
also	NULL
mediated	NULL
the	NULL
transendothelial	NULL
migration	NULL
of	NULL
monocytes	NULL
.	NULL

First	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
on	NULL
the	NULL
transendothelial	NULL
migration	NULL
of	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
.	NULL

To	NULL
study	NULL
the	NULL
migration	NULL
of	NULL
monocyte-like	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
RBC	NULL
,	NULL
we	NULL
used	NULL
fluorescent-labeled	NULL
HL-60	NULL
cells	NULL
,	NULL
so	NULL
as	NULL
to	NULL
distinguish	NULL
the	NULL
migration	NULL
of	NULL
monocytes	NULL
from	NULL
that	NULL
of	NULL
RBC	NULL
across	NULL
the	NULL
endothelial	NULL
cell	NULL
monolayer	NULL
.	NULL

The	NULL
migration	NULL
of	NULL
fluorescently	NULL
labeled	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
was	NULL
monitored	NULL
by	NULL
fluorescence	NULL
microscopy	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
4A	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
SS	NULL
RBC	NULL
(	NULL
hematocrit	NULL
2	NULL
%	NULL
)	NULL
with	NULL
E-CM	NULL
to	NULL
confluent	NULL
monolayers	NULL
of	NULL
HUVEC	NULL
cultured	NULL
in	NULL
Transwell	NULL
chambers	NULL
resulted	NULL
in	NULL
an	NULL
approximately	NULL
twofold	NULL
increase	NULL
in	NULL
the	NULL
number	NULL
of	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
migrating	NULL
across	NULL
the	NULL
SULTANA	NULL
ET	NULL
AL	NULL
endothelial	NULL
cell	NULL
monolayer	NULL
at	NULL
2	NULL
and	NULL
4	NULL
hours	NULL
posttreatment	NULL
with	NULL
SS	NULL
RBC	NULL
.	NULL

Normal	NULL
(	NULL
AA	NULL
)	NULL
RBC	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
E-CM	NULL
failed	NULL
to	NULL
increase	NULL
the	NULL
migration	NULL
of	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
above	NULL
basal	NULL
level	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
.	NULL

As	NULL
previously	NULL
observed	NULL
``	NULL
with	NULL
15-HPETE-induced	NULL
transendothelial	NULL
migration	NULL
of	NULL
monocytes	NULL
,	NULL
an	NULL
antibody	NULL
to	NULL
PECAM-1	NULL
inhibited	NULL
by	NULL
70	NULL
%	NULL
+	NULL
11	NULL
%	NULL
the	NULL
SS	NULL
RBC-induced	NULL
migration	NULL
of	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
across	NULL
HUVEC	NULL
monolayers	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
,	NULL
whereas	NULL
a	NULL
control	NULL
antibody	NULL
to	NULL
ICAM-2	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
transendothelial	NULL
migration	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

Our	NULL
previous	NULL
studies	NULL
``	NULL
``	NULL
showed	NULL
that	NULL
15-HPETE	NULL
induced	NULL
the	NULL
phosphorylation	NULL
of	NULL
PECAM-1	NULL
and	NULL
,	NULL
concomitant	NULL
with	NULL
it	NULL
,	NULL
increased	NULL
the	NULL
transendothelial	NULL
migration	NULL
of	NULL
monocytes	NULL
;	NULL
thus	NULL
we	NULL
investigated	NULL
whether	NULL
the	NULL
transendothelial	NULL
migration	NULL
of	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
induced	NULL
by	NULL
SS	NULL
RBC	NULL
was	NULL
linked	NULL
to	NULL
PECAM-1	NULL
phosphorylation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
4B	NULL
,	NULL
pretreatment	NULL
of	NULL
HUVEC	NULL
with	NULL
the	NULL
PKC	NULL
inhibitor	NULL
GF-109203X	NULL
(	NULL
20	NULL
nmol/L	NULL
)	NULL
``	NULL
for	NULL
30	NULL
minutes	NULL
,	NULL
followed	NULL
by	NULL
incubation	NULL
with	NULL
SS	NULL
RBC	NULL
and	NULL
E-CM	NULL
,	NULL
resulted	NULL
in	NULL
an	NULL
approximate	NULL
60	NULL
%	NULL
decrease	NULL
in	NULL
the	NULL
transendothelial	NULL
migration	NULL
of	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
at	NULL
the	NULL
2-hour	NULL
time	NULL
point	NULL
.	NULL

As	NULL
predicted	NULL
,	NULL
augmentation	NULL
of	NULL
PECAM-1	NULL
phosphorylation	NULL
with	NULL
the	NULL
protein	NULL
phosphatase	NULL
inhibitor	NULL
Calyculin	NULL
A	NULL
(	NULL
2	NULL
nmol/L	NULL
)	NULL
*	NULL
``	NULL
increased	NULL
by	NULL
~70	NULL
%	NULL
(	NULL
P	NULL
<	NULL
.001	NULL
)	NULL
the	NULL
transendothelial	NULL
migration	NULL
of	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
,	NULL
relative	NULL
to	NULL
endothelial	NULL
cells	NULL
incubated	NULL
with	NULL
SS	NULL
RBC	NULL
and	NULL
E-CM	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
indicate	NULL
that	NULL
there	NULL
may	NULL
be	NULL
a	NULL
direct	NULL
or	NULL
causal	NULL
relationship	NULL
between	NULL
phosphorylation	NULL
of	NULL
PECAM-1	NULL
and	NULL
transendothelial	NULL
migration	NULL
of	NULL
monocytes	NULL
.	NULL

Treatment	NULL
of	NULL
HUVEC	NULL
with	NULL
antioxidant	NULL
probucol	NULL
(	NULL
50	NULL
umol/L	NULL
)	NULL
reduced	NULL
by	NULL
~70	NULL
%	NULL
the	NULL
migration	NULL
of	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
(	NULL
Fig	NULL
4C	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
4C	NULL
,	NULL
pretreatment	NULL
of	NULL
HUVEC	NULL
with	NULL
GSH-ethylester	NULL
,	NULL
which	NULL
causes	NULL
elevation	NULL
of	NULL
intracellular	NULL
GSH	NULL
levels	NULL
,	NULL
``	NULL
``	NULL
for	NULL
24	NULL
hours	NULL
reduced	NULL
by	NULL
~90	NULL
%	NULL
the	NULL
migration	NULL
of	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
treatment	NULL
of	NULL
HUVEC	NULL
with	NULL
BSO	NULL
to	NULL
prevent	NULL
GSH	NULL
synthesis*	NULL
``	NULL
increased	NULL
by	NULL
50	NULL
%	NULL
the	NULL
migration	NULL
of	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
induced	NULL
by	NULL
SS	NULL
RBC	NULL
plus	NULL
E-CM	NULL
(	NULL
Fig	NULL
4C	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
SS	NULL
RBC	NULL
on	NULL
transendothelial	NULL
migration	NULL
of	NULL
human	NULL
PBM	NULL
.	NULL

-	NULL
Because	NULL
our	NULL
studies	NULL
showed	NULL
that	NULL
incubation	NULL
of	NULL
HUVEC	NULL
with	NULL
SS	NULL
RBC	NULL
in	NULL
presence	NULL
of	NULL
E-CM	NULL
increased	NULL
transendothelial	NULL
migration	NULL
of	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
(	NULL
a	NULL
transformed	NULL
cell	NULL
line	NULL
)	NULL
;	NULL
it	NULL
was	NULL
of	NULL
interest	NULL
to	NULL
examine	NULL
whether	NULL
freshly	NULL
isolated	NULL
monocytes	NULL
from	NULL
human	NULL
peripheral	NULL
blood	NULL
exhibited	NULL
similar	NULL
migration	NULL
characteristics	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
4D	NULL
,	NULL
incubation	NULL
of	NULL
HUVEC	NULL
with	NULL
SS	NULL
RBC	NULL
plus	NULL
E-CM	NULL
resulted	NULL
in	NULL
twofold	NULL
increase	NULL
in	NULL
the	NULL
migration	NULL
of	NULL
human	NULL
PBM	NULL
at	NULL
2-hour	NULL
time	NULL
point	NULL
as	NULL
was	NULL
observed	NULL
for	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
.	NULL

Additionally	NULL
,	NULL
antibody	NULL
to	NULL
PECAM-1	NULL
inhibited	NULL
the	NULL
migration	NULL
of	NULL
monocytes	NULL
by	NULL
~80	NULL
%	NULL
(	NULL
Fig	NULL
4D	NULL
)	NULL
.	NULL

However	NULL
,	NULL
control	NULL
antibody	NULL
to	NULL
ICAM-2	NULL
had	NULL
no	NULL
affect	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
KYRGDS	NULL
,	NULL
but	NULL
not	NULL
a	NULL
variant	NULL
peptide	NULL
AGDV	NULL
,	NULL
blocked	NULL
the	NULL
transendothelial	NULL
migration	NULL
of	NULL
human	NULL
PBM	NULL
by	NULL
70	NULL
%	NULL
.	NULL

Phosphorylation	NULL
of	NULL
PECAM-1	NULL
in	NULL
HUVEC	NULL
induced	NULL
by	NULL
SS	NULL
RBC	NULL
.	NULL

_	NULL
As	NULL
shown	NULL
in	NULL
Fig	NULL
5	NULL
,	NULL
incubation	NULL
of	NULL
``	NULL
P-labeled	NULL
HUVEC	NULL
with	NULL
SS	NULL
RBC	NULL
plus	NULL
E-CM	NULL
resulted	NULL
in	NULL
a	NULL
time-dependent	NULL
increase	NULL
in	NULL
PECAM-1	NULL
phosphorylation	NULL
.	NULL

We	NULL
observed	NULL
approximately	NULL
a	NULL
sixfold	NULL
(	NULL
638	NULL
%	NULL
+	NULL
220	NULL
%	NULL
)	NULL
increase	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
PECAM-1	NULL
at	NULL
1	NULL
hour	NULL
.	NULL

At	NULL
the	NULL
2-hour	NULL
time	NULL
point	NULL
;	NULL
the	NULL
phosphorylation	NULL
of	NULL
PECAM-1	NULL
showed	NULL
a	NULL
fivefold	NULL
increase	NULL
above	NULL
the	NULL
basal	NULL
level	NULL
.	NULL

Conversely	NULL
,	NULL
normal	NULL
(	NULL
AA	NULL
)	NULL
RBC	NULL
,	NULL
under	NULL
the	NULL
same	NULL
condi-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

SS	NULL
RBC-INDUCED	NULL
OXIDANT	NULL
STRESS	NULL
IN	NULL
ENDOTHELIUM	NULL
3931	NULL
A	NULL
4	NULL
r	NULL
|	NULL
T	NULL
7	NULL
B	NULL
an	NULL
_	NULL
p	NULL
<	NULL
0.001	NULL
Calyculin	NULL
A	NULL
&	NULL
C	NULL
3	NULL
s	NULL
3	NULL
9	NULL
Int	NULL
aF109203X	NULL
p	NULL
<	NULL
o.o1	NULL
a	NULL
0	NULL
|	NULL
$	NULL
3	NULL
w	NULL
Ab-ICAM-2	NULL
-I	NULL
o	NULL
2	NULL
-	NULL
6	NULL
bud	NULL
-	NULL
|	NULL
1/	NULL
Ab-PECAM-1	NULL
p	NULL
<	NULL
o.01	NULL
3	NULL
/	NULL
2	NULL
[	NULL
s	NULL
1	NULL
<	NULL
SS	NULL
RBC+E-CM	NULL
p	NULL
<	NULL
0.001	NULL
.I	NULL
-+-	NULL
None	NULL
s	NULL
{	NULL
-=-	NULL
AA	NULL
ABC+E-CM	NULL
|	NULL
--	NULL
S8	NULL
ABC+E-CM	NULL
None	NULL
—-—4	NULL
p	NULL
<	NULL
0.001	NULL
0	NULL
T	NULL
l	NULL
T	NULL
I	NULL
T	NULL
l	NULL
T	NULL
E	NULL
|	NULL
T	NULL
I	NULL
I	NULL
I	NULL
T	NULL
I	NULL
T	NULL
I	NULL
T	NULL
I	NULL
I	NULL
I	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Time	NULL
(	NULL
hr	NULL
)	NULL
Migrated	NULL
HL-60	NULL
Cells	NULL
at	NULL
2	NULL
hr	NULL
(	NULL
x	NULL
10	NULL
``	NULL
)	NULL
6	NULL
s	NULL
|	NULL
a	NULL
g	NULL
-	NULL
T	NULL
_	NULL
AGDV	NULL
z	NULL
o	NULL
LJ	NULL
[	NULL
|	NULL
Pu	NULL
z	NULL
6	NULL
B	NULL
4	NULL
-	NULL
2	NULL
kyRabs	NULL
xc	NULL
w	NULL
-	NULL
E	NULL
w	NULL
«	NULL
o	NULL
+	NULL
o	NULL
a	NULL
|	NULL
P4	NULL
T	NULL
2	NULL
x	NULL
--	NULL
$	NULL
$	NULL
RBC+E-CM	NULL
€	NULL
_|	NULL
80	NULL
9	NULL
=	NULL
4	NULL
None	NULL
0	NULL
-	NULL
(	NULL
l	NULL
|	NULL
T	NULL
‘	NULL
u	NULL
I	NULL
T	NULL
C	NULL
None	NULL
-	NULL
§§	NULL
RBC+E-CM	NULL
Probucol	NULL
_	NULL
GSH-EE	NULL
BSO	NULL
0	NULL
1	NULL
2	NULL
3	NULL
+58	NULL
RBC+E-CM	NULL
Migrated	NULL
monocytes	NULL
(	NULL
x	NULL
10	NULL
``	NULL
)	NULL
at	NULL
2	NULL
hr	NULL
D	NULL
Fig	NULL
4	NULL
.	NULL

Migration	NULL
of	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
and	NULL
PBM	NULL
across	NULL
HUVEC	NULL
monolayer	NULL
in	NULL
response	NULL
to	NULL
incubation	NULL
with	NULL
RBC	NULL
.	NULL

HUVEC	NULL
were	NULL
grow	NULL
n	NULL
to	NULL
confluence	NULL
on	NULL
fibronectin-coated	NULL
porous	NULL
membranes	NULL
(	NULL
Transwell	NULL
,	NULL
Cat	NULL
.	NULL

#	NULL
40492	NULL
,	NULL
Biocoat	NULL
cell	NULL
culture	NULL
inserts	NULL
,	NULL
Becton-Dickinson	NULL
)	NULL
.	NULL

To	NULL
the	NULL
upper	NULL
compartment	NULL
,	NULL
RPMI-1640	NULL
containing	NULL
FCS	NULL
was	NULL
added	NULL
,	NULL
followed	NULL
by	NULL
RBC	NULL
(	NULL
2	NULL
%	NULL
Hct	NULL
)	NULL
and	NULL
E-CM	NULL
(	NULL
100	NULL
mg/mL	NULL
)	NULL
and	NULL
fluorescently	NULL
labeled	NULL
vitamin	NULL
D	NULL
;	NULL
-differentiated	NULL
HL-60	NULL
cells	NULL
or	NULL
PBM	NULL
(	NULL
0.5	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
well	NULL
)	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
time	NULL
points	NULL
,	NULL
aliquots	NULL
were	NULL
removed	NULL
from	NULL
the	NULL
lower	NULL
compartment	NULL
of	NULL
the	NULL
Transwell	NULL
chamber	NULL
for	NULL
counting	NULL
of	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
SS	NULL
RBC	NULL
,	NULL
n	NULL
=	NULL
4	NULL
(	NULL
three	NULL
different	NULL
donors	NULL
)	NULL
,	NULL
and	NULL
three	NULL
independent	NULL
determinations	NULL
for	NULL
AA	NULL
RBC	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Time	NULL
course	NULL
of	NULL
HL-60	NULL
cells	NULL
transendothelial	NULL
migration	NULL
.	NULL

(	NULL
B	NULL
)	NULL
HUVEC	NULL
were	NULL
incubated	NULL
with	NULL
inhibitors	NULL
(	NULL
MoAb	NULL
to	NULL
human	NULL
PECAM-1	NULL
(	NULL
10	NULL
g/mL	NULL
)	NULL
;	NULL
MoAb	NULL
to	NULL
ICAM-2	NULL
(	NULL
10	NULL
g/mL	NULL
)	NULL
;	NULL
GF	NULL
109203X	NULL
(	NULL
20	NULL
nmol/L	NULL
)	NULL
;	NULL
and	NULL
Calyculin	NULL
A	NULL
,	NULL
(	NULL
2	NULL
nmol/L	NULL
)	NULL
for	NULL
45	NULL
minutes	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
SS	NULL
RBC	NULL
(	NULL
2	NULL
%	NULL
Het	NULL
)	NULL
and	NULL
E-CM	NULL
.	NULL

(	NULL
C	NULL
)	NULL
HUVEC	NULL
were	NULL
preincubated	NULL
with	NULL
either	NULL
antioxidant	NULL
(	NULL
probucol	NULL
,	NULL
50	NULL
wmol/L	NULL
)	NULL
for	NULL
45	NULL
minutes	NULL
or	NULL
GSH	NULL
effectors	NULL
(	NULL
GSH-EE	NULL
,	NULL
0.5	NULL
mmol/L	NULL
and	NULL
BSO	NULL
,	NULL
100	NULL
wmol/L	NULL
)	NULL
for	NULL
24	NULL
hours	NULL
,	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
SS	NULL
RBC	NULL
(	NULL
2	NULL
%	NULL
Hct	NULL
)	NULL
and	NULL
HL-60	NULL
cells	NULL
.	NULL

(	NULL
D	NULL
)	NULL
HUVEC	NULL
were	NULL
incubated	NULL
with	NULL
MoAb	NULL
to	NULL
human	NULL
PECAM-1	NULL
(	NULL
10	NULL
pg/mL	NULL
)	NULL
;	NULL
KYRGDS	NULL
,	NULL
(	NULL
100	NULL
pmol/L	NULL
)	NULL
;	NULL
and	NULL
AGDYV	NULL
,	NULL
(	NULL
100	NULL
pmol/L	NULL
)	NULL
for	NULL
45	NULL
minutes	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
SS	NULL
RBC	NULL
(	NULL
2	NULL
%	NULL
Het	NULL
)	NULL
and	NULL
E-CM	NULL
(	NULL
100	NULL
mg/	NULL
mL	NULL
)	NULL
.	NULL

This	NULL
w	NULL
as	NULL
follow	NULL
ed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
fluorescently	NULL
labeled	NULL
PBM	NULL
.	NULL

The	NULL
transmigrated	NULL
monocyte	NULL
cells	NULL
were	NULL
counted	NULL
at	NULL
2	NULL
hours	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
+	NULL
SD	NULL
for	NULL
three	NULL
different	NULL
donors	NULL
RBC	NULL
.	NULL

tions	NULL
,	NULL
showed	NULL
no	NULL
induction	NULL
of	NULL
PECAM-1	NULL
phosphorylation	NULL
(	NULL
data	NULL
ethyl	NULL
ester	NULL
,	NULL
inhibited	NULL
by	NULL
~85	NULL
%	NULL
the	NULL
SS	NULL
RBC	NULL
plus	NULL
E-CM-induced	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
6	NULL
,	NULL
SS	NULL
RBC-induced	NULL
phosphoryla-	NULL
phosphorylation	NULL
.	NULL

Conversely	NULL
,	NULL
inhibition	NULL
of	NULL
intracellular	NULL
synthe-tion	NULL
of	NULL
PECAM-1	NULL
in	NULL
HUVEC	NULL
was	NULL
approximately	NULL
75	NULL
%	NULL
inhibited	NULL
sis	NULL
of	NULL
GSH	NULL
by	NULL
pretreatment	NULL
of	NULL
HUVEC	NULL
with	NULL
BSO	NULL
elevated	NULL
by	NULL
the	NULL
PKC	NULL
inhibitor	NULL
GF-109203	NULL
%	NULL
X	NULL
,	NULL
*°	NULL
but	NULL
not	NULL
by	NULL
the	NULL
adenylate	NULL
PECAM-1	NULL
phosphorylation	NULL
by	NULL
~50	NULL
%	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
cyclase	NULL
inhibitor	NULL
SQ-22536.4°	NULL
However	NULL
,	NULL
treatment	NULL
of	NULL
HUVEC	NULL
that	NULL
redox	NULL
state	NULL
(	NULL
GSH/GSSG	NULL
levels	NULL
)	NULL
of	NULL
endothelial	NULL
cells	NULL
in	NULL
with	NULL
a	NULL
protein	NULL
phosphatase	NULL
inhibitor	NULL
,	NULL
Calyculin	NULL
A	NULL
,	NULL
``	NULL
in	NULL
the	NULL
response	NULL
to	NULL
the	NULL
interaction	NULL
with	NULL
SS	NULL
RBC	NULL
can	NULL
affect	NULL
the	NULL
presence	NULL
of	NULL
SS	NULL
RBC	NULL
and	NULL
E-CM	NULL
,	NULL
increased	NULL
PECAM-1	NULL
phosphor-	NULL
phosphorylation	NULL
of	NULL
PECAM-1	NULL
.	NULL

ylation	NULL
by	NULL
~35	NULL
%	NULL
above	NULL
the	NULL
level	NULL
induced	NULL
by	NULL
SS	NULL
RBC	NULL
plus	NULL
E-CM	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
phosphorylation	NULL
of	NULL
PECAM-1	NULL
DISCUSSION	NULL
induced	NULL
by	NULL
SS	NULL
RBC	NULL
+	NULL
E-CM	NULL
was	NULL
~65	NULL
%	NULL
inhibited	NULL
by	NULL
Vascular	NULL
occlusion	NULL
leading	NULL
to	NULL
episodes	NULL
of	NULL
painful	NULL
crises	NULL
and	NULL
antioxidant	NULL
probucol	NULL
,	NULL
indicating	NULL
the	NULL
importance	NULL
of	NULL
oxidant	NULL
damage	NULL
to	NULL
various	NULL
end	NULL
organs	NULL
is	NULL
the	NULL
major	NULL
cause	NULL
of	NULL
morbidity	NULL
in	NULL
stress	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
PECAM-1	NULL
.	NULL

Addition	NULL
of	NULL
GSH-	NULL
adults	NULL
and	NULL
older	NULL
children	NULL
with	NULL
SCD.5	NULL
%	NULL
~	NULL
It	NULL
is	NULL
recognized	NULL
that	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

SULTANA	NULL
ET	NULL
AL	NULL
Fig	NULL
5	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
phosphorylation	NULL
of	NULL
PECAM-1	NULL
in	NULL
HUVEC	NULL
in	NULL
response	NULL
to	NULL
incubation	NULL
with	NULL
SS	NULL
RBC	NULL
.	NULL

HUVEC	NULL
were	NULL
labeled	NULL
with	NULL
*°P	NULL
and	NULL
incubated	NULL
with	NULL
SS	NULL
RBC	NULL
(	NULL
2	NULL
%	NULL
Hct	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
period	NULL
and	NULL
then	NULL
processed	NULL
for	NULL
immunoprecipitation	NULL
with	NULL
PECAM-1	NULL
antibody	NULL
.	NULL

The	NULL
immunoprecipitate	NULL
was	NULL
subjected	NULL
to	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
and	NULL
radioactivity	NULL
quantitated	NULL
in	NULL
the	NULL
gel	NULL
lane	NULL
corresponding	NULL
to	NULL
PECAM-1	NULL
(	NULL
130	NULL
kD	NULL
)	NULL
by	NULL
Ambis	NULL
radioge	NULL
!	NULL

scanner	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
data	NULL
is	NULL
presented	NULL
as	NULL
percent	NULL
increase	NULL
in	NULL
the	NULL
incorporation	NULL
of	NULL
°P	NULL
in	NULL
PECAM-1	NULL
,	NULL
assigning	NULL
the	NULL
value	NULL
of	NULL
100	NULL
%	NULL
for	NULL
``	NULL
°P	NULL
incorporated	NULL
into	NULL
PECAM-1	NULL
in	NULL
untreated	NULL
HUVEC	NULL
.	NULL

Data	NULL
are	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
n	NULL
=	NULL
3	NULL
,	NULL
with	NULL
each	NULL
experiment	NULL
run	NULL
in	NULL
duplicate	NULL
for	NULL
indicated	NULL
time	NULL
points	NULL
,	NULL
except	NULL
for	NULL
1-hour	NULL
period	NULL
3932	NULL
900	NULL
i	NULL
Sad	NULL
'	NULL
w	NULL
‘	NULL
0	NULL
025ng	NULL
?	NULL

&	NULL
,	NULL
2004	NULL
-	NULL
750	NULL
ps	NULL
<	NULL
C	NULL
©	NULL
u-IA	NULL
22	NULL
Boo	NULL
C	NULL
c	NULL
o	NULL
3	NULL
©	NULL
e	NULL
0	NULL
cs	NULL
lav	NULL
s	NULL
300	NULL
&	NULL
®	NULL
150	NULL
0	NULL
’	NULL
I	NULL
|	NULL
T	NULL
|	NULL
0	NULL
1	NULL
2	NULL
3	NULL
Time	NULL
(	NULL
hr	NULL
)	NULL
abnormal	NULL
adherence	NULL
of	NULL
SS	NULL
RBC	NULL
to	NULL
endothelium	NULL
is	NULL
a	NULL
key	NULL
participant	NULL
in	NULL
the	NULL
vaso-occlusive	NULL
events	NULL
,	NULL
``	NULL
``	NULL
because	NULL
studies	NULL
showed	NULL
that	NULL
the	NULL
extent	NULL
of	NULL
adherence	NULL
of	NULL
SS	NULL
RBC	NULL
to	NULL
cultured	NULL
endothelial	NULL
cells	NULL
correlated	NULL
with	NULL
the	NULL
clinical	NULL
severity	NULL
of	NULL
vaso-occlusive	NULL
crises	NULL
in	NULL
SCD.5®	NULL
However	NULL
,	NULL
SCD	NULL
patients	NULL
with	NULL
identical	NULL
biochemical	NULL
defects	NULL
in	NULL
their	NULL
-globin	NULL
genes	NULL
show	NULL
a	NULL
wide	NULL
variability	NULL
in	NULL
the	NULL
frequency	NULL
and	NULL
clinical	NULL
severity	NULL
of	NULL
vasoocclu-sive	NULL
crises	NULL
,	NULL
and	NULL
can	NULL
remain	NULL
asymptomatic	NULL
for	NULL
prolonged	NULL
peri-ods	NULL
,	NULL
``	NULL
``	NULL
indicating	NULL
that	NULL
additional	NULL
factors	NULL
must	NULL
contribute	NULL
to	NULL
the	NULL
pathophysiology	NULL
of	NULL
vaso-occlusion	NULL
.	NULL
'	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
biochemical	NULL
properties	NULL
of	NULL
sickle	NULL
cells	NULL
,	NULL
including	NULL
membrane	NULL
characteristics	NULL
,	NULL
microvascular	NULL
dynamics	NULL
,	NULL
*	NULL
``	NULL
``	NULL
tissue	NULL
hypoxia	NULL
,	NULL
``	NULL
``	NULL
and	NULL
perturbation	NULL
of	NULL
vascular	NULL
endothelium	NULL
,	NULL
``	NULL
contribute	NULL
to	NULL
the	NULL
pathogenesis	NULL
of	NULL
the	NULL
vaso-occlusive	NULL
process	NULL
.	NULL

We	NULL
hypothesized	NULL
that	NULL
the	NULL
adherence	NULL
of	NULL
SS	NULL
RBC	NULL
to	NULL
endothelium	NULL
may	NULL
+BSO	NULL
+GSH-EE	NULL
+Probucol	NULL
+Calyculin	NULL
A	NULL
+	NULL
$	NULL
Q22536	NULL
Fig	NULL
6	NULL
.	NULL

-	NULL
Effect	NULL
of	NULL
inhibitors	NULL
on	NULL
the	NULL
°P	NULL
incorporation	NULL
in	NULL
PECAM-1	NULL
in	NULL
HUVEC	NULL
on	NULL
incubation	NULL
with	NULL
RBC	NULL
.	NULL

``	NULL
P-labeled	NULL
HUVEC	NULL
were	NULL
incubated	NULL
with	NULL
inhibitors	NULL
+GF109203X	NULL
either	NULL
for	NULL
45	NULL
minute	NULL
(	NULL
GF	NULL
109203X	NULL
,	NULL
20	NULL
nmol/L	NULL
;	NULL
SQ	NULL
22536	NULL
,	NULL
2	NULL
pmol/L	NULL
;	NULL
calyculin	NULL
A	NULL
,	NULL
2	NULL
nmol/L	NULL
;	NULL
probucol	NULL
,	NULL
50	NULL
SS	NULL
RBC+E-CM	NULL
pmol/L	NULL
;	NULL
or	NULL
for	NULL
24	NULL
hours	NULL
(	NULL
GSH-EE	NULL
,	NULL
0.5	NULL
mmol/L	NULL
and	NULL
BSO	NULL
,	NULL
100	NULL
mol/L	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
1-hour	NULL
incubation	NULL
with	NULL
SS	NULL
RBC	NULL
(	NULL
2	NULL
%	NULL
Hct	NULL
)	NULL
and	NULL
E-CM	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
+	NULL
SD	NULL
for	NULL
three	NULL
different	NULL
SS	NULL
RBC	NULL
donors	NULL
,	NULL
in	NULL
duplicate	NULL
determinations	NULL
,	NULL
relative	NULL
to	NULL
untreated	NULL
HUVEC	NULL
(	NULL
none	NULL
)	NULL
.	NULL

|	NULL
(	NULL
n	NULL
=	NULL
7	NULL
)	NULL
.	NULL

°P	NULL
incorporated	NULL
into	NULL
PECAM-1	NULL
was	NULL
638	NULL
%	NULL
+	NULL
220	NULL
%	NULL
at	NULL
1-hour	NULL
time	NULL
point	NULL
,	NULL
with	NULL
a	NULL
range	NULL
of	NULL
410	NULL
%	NULL
to	NULL
4	NULL
850	NULL
%	NULL
.	NULL

The	NULL
replicate	NULL
data	NULL
for	NULL
the	NULL
same	NULL
donor	NULL
sample	NULL
showed	NULL
less	NULL
than	NULL
15	NULL
%	NULL
difference	NULL
in	NULL
the	NULL
P	NULL
incorporation	NULL
into	NULL
PECAM-1	NULL
.	NULL

cause	NULL
injury	NULL
or	NULL
activation	NULL
of	NULL
endothelium	NULL
leading	NULL
to	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
CAMs	NULL
that	NULL
can	NULL
lead	NULL
to	NULL
the	NULL
increased	NULL
adherence	NULL
of	NULL
PMN	NULL
and	NULL
monocytes	NULL
to	NULL
the	NULL
damaged/activated	NULL
endothelium	NULL
through	NULL
counter	NULL
ligands	NULL
,	NULL
as	NULL
well	NULL
as	NULL
to	NULL
the	NULL
additional	NULL
adherence	NULL
of	NULL
SS	NULL
reticulocytes	NULL
through	NULL
the	NULL
af	NULL
;	NULL
ligand	NULL
to	NULL
VCAM-1.192	NULL
%	NULL
55	NULL
The	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
and	NULL
leukocytes	NULL
to	NULL
injured/activated	NULL
microvascular	NULL
endothelium	NULL
can	NULL
adversely	NULL
affect	NULL
the	NULL
blood	NULL
flow	NULL
in	NULL
the	NULL
capillary	NULL
.	NULL

Such	NULL
flow	NULL
conditions	NULL
will	NULL
favor	NULL
the	NULL
direct	NULL
contact	NULL
of	NULL
SS	NULL
RBC	NULL
with	NULL
neutrophils	NULL
and	NULL
concomitant	NULL
attachment	NULL
of	NULL
PMN	NULL
to	NULL
SS	NULL
RBC	NULL
,	NULL
promoting	NULL
the	NULL
risk	NULL
of	NULL
vessel	NULL
occlusion	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
observed	NULL
that	NULL
such	NULL
recognition	NULL
of	NULL
SS	NULL
RBC	NULL
by	NULL
PMN	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
PMN	NULL
,	NULL
``	NULL
which	NULL
can	NULL
directly	NULL
damage	NULL
the	NULL
vascular	NULL
endothelium	NULL
through	NULL
the	NULL
generation	NULL
and	NULL
release	NULL
of	NULL
superoxide	NULL
radicals	NULL
.	NULL

The	NULL
injury	NULL
or	NULL
activation	NULL
of	NULL
vascular	NULL
endothelium	NULL
in	NULL
vivo	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
patients	NULL
T	NULL
|	NULL
150	NULL
Relative	NULL
PECAM-1	NULL
phosphorylation	NULL
(	NULL
%	NULL
)	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

SS	NULL
RBC-INDUCED	NULL
OXIDANT	NULL
STRESS	NULL
IN	NULL
ENDOTHELIUM	NULL
with	NULL
sickle	NULL
cell	NULL
anemia	NULL
,	NULL
wherein	NULL
one	NULL
observes	NULL
the	NULL
presence	NULL
of	NULL
increased	NULL
number	NULL
of	NULL
activated	NULL
circulating	NULL
endothelial	NULL
cells	NULL
in	NULL
blood	NULL
samples	NULL
.	NULL
``	NULL

''	NULL
``	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
by	NULL
which	NULL
the	NULL
adherence	NULL
of	NULL
SS	NULL
RBC	NULL
to	NULL
cultured	NULL
endothelial	NULL
cells	NULL
,	NULL
proximal	NULL
sites	NULL
of	NULL
stasis	NULL
of	NULL
SS	NULL
RBC	NULL
in	NULL
the	NULL
vasculature	NULL
,	NULL
potentially	NULL
augments	NULL
the	NULL
adherence	NULL
of	NULL
SS	NULL
reticulocytes	NULL
,	NULL
and	NULL
promotes	NULL
the	NULL
adherence	NULL
and	NULL
migration	NULL
of	NULL
monocytes	NULL
across	NULL
the	NULL
endothelial	NULL
cell	NULL
monolayer	NULL
.	NULL

SS	NULL
RBC	NULL
,	NULL
because	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
unstable	NULL
SS	NULL
hemoglobin	NULL
and	NULL
spontaneous	NULL
auto-oxidation	NULL
of	NULL
iron	NULL
in	NULL
sickle	NULL
heme	NULL
``	NULL
generate	NULL
excessive	NULL
(	NULL
two-	NULL
to	NULL
threefold	NULL
)	NULL
amounts	NULL
of	NULL
ROS	NULL
(	NULL
Oy	NULL
,	NULL
OH	NULL
,	NULL
and	NULL
H	NULL
;	NULL
O	NULL
;	NULL
)	NULL
(	NULL
ROS	NULL
)	NULL
compared	NULL
with	NULL
control	NULL
normal	NULL
RBC	NULL
.	NULL
``	NULL

We	NULL
show	NULL
here	NULL
that	NULL
HUVEC	NULL
incubated	NULL
with	NULL
SS	NULL
RBC	NULL
generates	NULL
threefold	NULL
increased	NULL
amount	NULL
of	NULL
lipid	NULL
peroxides	NULL
(	NULL
mea-sured	NULL
as	NULL
thiobarbituric	NULL
acid	NULL
reactive	NULL
substances	NULL
,	NULL
TBARS	NULL
)	NULL
.	NULL

However	NULL
,	NULL
HUVEC	NULL
incubated	NULL
with	NULL
SS	NULL
RBC	NULL
plus	NULL
vWf	NULL
(	NULL
E-CM	NULL
)	NULL
resulted	NULL
in	NULL
an	NULL
additional	NULL
twofold	NULL
TBARS	NULL
formation	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
TBARS	NULL
by	NULL
HUVEC	NULL
is	NULL
inhibited	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
free	NULL
radical	NULL
scavenging	NULL
enzymes	NULL
,	NULL
superoxide	NULL
dismutase	NULL
,	NULL
and	NULL
catalase	NULL
.	NULL

Moreover	NULL
,	NULL
blocking	NULL
the	NULL
adherence	NULL
of	NULL
SS	NULL
RBC	NULL
to	NULL
endothelial	NULL
cells	NULL
,	NULL
reduced	NULL
TBARS	NULL
formation	NULL
.	NULL

We	NULL
also	NULL
measured	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
in	NULL
HUVEC	NULL
,	NULL
another	NULL
indicator	NULL
of	NULL
cellular	NULL
oxidant	NULL
stress	NULL
.	NULL
'	NULL

''	NULL
Our	NULL
results	NULL
show	NULL
that	NULL
the	NULL
adherence/contact	NULL
of	NULL
SS	NULL
RBC	NULL
to	NULL
endothelial	NULL
cells	NULL
,	NULL
mediated	NULL
by	NULL
multimers	NULL
of	NULL
vW1	NULL
,	NULL
led	NULL
to	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

This	NULL
activation	NULL
of	NULL
NF-kB	NULL
in	NULL
HUVEC	NULL
required	NULL
the	NULL
adhesion/contact	NULL
of	NULL
SS	NULL
RBC	NULL
and	NULL
was	NULL
also	NULL
inhibited	NULL
by	NULL
antioxidants	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
adherence/contact	NULL
of	NULL
SS	NULL
RBC	NULL
mediated	NULL
by	NULL
multimers	NULL
of	NULL
vW1	NULL
,	NULL
localizes	NULL
the	NULL
oxidant	NULL
stimulus	NULL
generated	NULL
by	NULL
SS	NULL
RBC	NULL
to	NULL
the	NULL
membrane	NULL
of	NULL
endothelial	NULL
cells	NULL
and	NULL
generates	NULL
intracellular	NULL
ROS	NULL
in	NULL
HUVEC	NULL
to	NULL
activate	NULL
NF-kB	NULL
.	NULL

The	NULL
intracellular	NULL
generation	NULL
of	NULL
ROS	NULL
(	NULL
oxidative	NULL
stress	NULL
)	NULL
could	NULL
occur	NULL
as	NULL
a	NULL
result	NULL
of	NULL
activation	NULL
of	NULL
NADH-oxidase	NULL
associated	NULL
with	NULL
the	NULL
plasma	NULL
membrane	NULL
of	NULL
endothelial	NULL
cells	NULL
.	NULL
``	NULL

We	NULL
show	NULL
that	NULL
incubation	NULL
of	NULL
HUVEC	NULL
with	NULL
SS	NULL
RBC	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
multimers	NULL
of	NULL
vWf	NULL
,	NULL
results	NULL
in	NULL
a	NULL
time-dependent	NULL
increase	NULL
in	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
CAMs	NULL
,	NULL
ICAM-1	NULL
,	NULL
E-selectin	NULL
,	NULL
and	NULL
VCAM-1	NULL
without	NULL
affecting	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
constitutively	NULL
expressed	NULL
ICAM-2	NULL
.	NULL

The	NULL
augmented	NULL
expression	NULL
of	NULL
VCAM-1	NULL
,	NULL
examined	NULL
in	NULL
this	NULL
study	NULL
,	NULL
was	NULL
observed	NULL
on	NULL
the	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
to	NULL
HUVEC	NULL
but	NULL
was	NULL
not	NULL
observed	NULL
when	NULL
vWf	NULL
(	NULL
E-CM	NULL
)	NULL
alone	NULL
was	NULL
added	NULL
to	NULL
HUVEC	NULL
.	NULL

Our	NULL
studies	NULL
show	NULL
that	NULL
the	NULL
cellular	NULL
oxidant	NULL
stress	NULL
generated	NULL
in	NULL
HUVEC	NULL
induced	NULL
by	NULL
SS	NULL
RBC	NULL
adherence	NULL
involves	NULL
a	NULL
glutathione	NULL
redox	NULL
step	NULL
because	NULL
agents	NULL
that	NULL
restore	NULL
intracellular	NULL
GSH	NULL
levels	NULL
prevent	NULL
VCAM-1	NULL
expression	NULL
,	NULL
whereas	NULL
an	NULL
opposite	NULL
effect	NULL
occurs	NULL
when	NULL
intracellular	NULL
GSH	NULL
levels	NULL
are	NULL
reduced	NULL
by	NULL
preincubation	NULL
of	NULL
HUVEC	NULL
with	NULL
BSO	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
GSH	NULL
synthesis	NULL
.	NULL

Conse-quently	NULL
,	NULL
agents	NULL
that	NULL
restore	NULL
intracellular	NULL
levels	NULL
of	NULL
GSH	NULL
levels	NULL
may	NULL
prevent	NULL
VCAM-1	NULL
expression	NULL
and	NULL
thus	NULL
could	NULL
have	NULL
beneficial	NULL
effects	NULL
on	NULL
microvascular	NULL
occlusion	NULL
.	NULL

Our	NULL
results	NULL
are	NULL
consonant	NULL
with	NULL
previous	NULL
studies	NULL
wherein	NULL
the	NULL
transcription	NULL
of	NULL
VCAM-1	NULL
in	NULL
human	NULL
vascular	NULL
endothelial	NULL
cells	NULL
,	NULL
induced	NULL
by	NULL
cytokine	NULL
IL-1	NULL
f	NULL
,	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
regulated	NULL
through	NULL
an	NULL
antioxidant-sensitive	NULL
mechanism	NULL
.	NULL

'*	NULL
Moreover	NULL
,	NULL
our	NULL
studies	NULL
show	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
free	NULL
radical	NULL
scavenger	NULL
enzymes	NULL
(	NULL
superoxide	NULL
dismutase	NULL
and	NULL
catalase	NULL
)	NULL
,	NULL
abrogated	NULL
SS	NULL
RBC	NULL
plus	NULL
E-CM-induced	NULL
VCAM-1	NULL
expression	NULL
.	NULL

Our	NULL
studies	NULL
indicate	NULL
that	NULL
ROS	NULL
formed	NULL
by	NULL
SS	NULL
RBC	NULL
or	NULL
SS	NULL
RBC	NULL
ligand-receptor	NULL
interaction	NULL
(	NULL
juxtacrine	NULL
3933	NULL
intercellular	NULL
signaling	NULL
)	NULL
``	NULL
and/or	NULL
both	NULL
result	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
(	NULL
oxidant	NULL
stress	NULL
)	NULL
intracellularly	NULL
in	NULL
endothelial	NULL
cells	NULL
,	NULL
which	NULL
activate	NULL
signaling	NULL
pathways	NULL
leading	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
redox-sensitive	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
.	NULL

Our	NULL
studies	NULL
show	NULL
here	NULL
,	NULL
for	NULL
the	NULL
first	NULL
time	NULL
,	NULL
that	NULL
interaction	NULL
of	NULL
SS	NULL
RBC	NULL
with	NULL
HUVEC	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
vWf	NULL
causes	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
migration	NULL
of	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
.	NULL

We	NULL
used	NULL
vitamin	NULL
D	NULL
,	NULL
-differentiated	NULL
human	NULL
HL-60	NULL
cells	NULL
(	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
)	NULL
,	NULL
because	NULL
this	NULL
cell	NULL
line	NULL
was	NULL
previously	NULL
used	NULL
as	NULL
a	NULL
reliable	NULL
model	NULL
of	NULL
in	NULL
vivo	NULL
monocyte	NULL
function	NULL
and	NULL
transendothelial	NULL
migration	NULL
studies	NULL
.	NULL
``	NULL

''	NULL
Similarly	NULL
,	NULL
the	NULL
transendothelial	NULL
migration	NULL
of	NULL
human	NULL
PBM	NULL
was	NULL
augmented	NULL
by	NULL
the	NULL
cellular	NULL
oxidant	NULL
stress	NULL
generated	NULL
by	NULL
the	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
to	NULL
endothelial	NULL
cells	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
the	NULL
transendothelial	NULL
migration	NULL
of	NULL
both	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
and	NULL
PBM	NULL
is	NULL
inhibited	NULL
by	NULL
an	NULL
antibody	NULL
to	NULL
PECAM-1	NULL
,	NULL
as	NULL
has	NULL
been	NULL
previously	NULL
observed	NULL
for	NULL
the	NULL
transendothelial	NULL
migration	NULL
of	NULL
monocytes	NULL
induced	NULL
by	NULL
lipoxygenase	NULL
metabolites	NULL
.	NULL
``	NULL

We	NULL
show	NULL
here	NULL
that	NULL
the	NULL
adherence	NULL
of	NULL
SS	NULL
RBC	NULL
to	NULL
HUVEC	NULL
,	NULL
mediated	NULL
by	NULL
vWf	NULL
,	NULL
leads	NULL
to	NULL
PECAM-1	NULL
phosphorylation	NULL
.	NULL

Both	NULL
the	NULL
SS	NULL
RBC	NULL
plus	NULL
E-CM-induced	NULL
phosphorylation	NULL
of	NULL
PECAM-1	NULL
and	NULL
the	NULL
transendothelial	NULL
migration	NULL
of	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
are	NULL
inhibited	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
inhibitor	NULL
,	NULL
indicating	NULL
the	NULL
direct	NULL
or	NULL
causal	NULL
involvement	NULL
of	NULL
PECAM-1	NULL
phosphorylation	NULL
in	NULL
mediating	NULL
the	NULL
flux	NULL
of	NULL
monocytes	NULL
across	NULL
the	NULL
endothelial	NULL
cell	NULL
monolayer	NULL
,	NULL
as	NULL
has	NULL
been	NULL
previously	NULL
observed	NULL
for	NULL
the	NULL
lipoxygenase	NULL
metabolite-induced	NULL
transendothelial	NULL
migration	NULL
of	NULL
monocytes	NULL
.	NULL
``	NULL

''	NULL
The	NULL
importance	NULL
of	NULL
PECAM-1	NULL
phosphorylation	NULL
to	NULL
transendothelial	NULL
migration	NULL
is	NULL
further	NULL
supported	NULL
by	NULL
findings	NULL
that	NULL
agents	NULL
such	NULL
as	NULL
the	NULL
phosphatase	NULL
inhibitor	NULL
Calyculin	NULL
A	NULL
,	NULL
which	NULL
increases	NULL
the	NULL
phosphorylation	NULL
of	NULL
PECAM-1	NULL
,	NULL
also	NULL
augment	NULL
monocyte	NULL
migration	NULL
over	NULL
and	NULL
above	NULL
the	NULL
level	NULL
of	NULL
SS	NULL
RBC	NULL
alone	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
antioxidants	NULL
and	NULL
modulators	NULL
of	NULL
intracellular	NULL
GSH	NULL
levels	NULL
,	NULL
which	NULL
affect	NULL
SS	NULL
RBC-induced	NULL
cellular	NULL
signals	NULL
,	NULL
also	NULL
affect	NULL
phosphorylation	NULL
of	NULL
PECAM-1	NULL
and	NULL
,	NULL
concomitant	NULL
with	NULL
it	NULL
,	NULL
the	NULL
transendothelial	NULL
migration	NULL
of	NULL
monocytes	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
our	NULL
studies	NULL
show	NULL
that	NULL
interaction	NULL
of	NULL
oxygenated	NULL
SS	NULL
RBC	NULL
with	NULL
HUVEC	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
multimers	NULL
of	NULL
vWf	NULL
,	NULL
generates	NULL
reactive	NULL
oxygen	NULL
species	NULL
(	NULL
oxidant	NULL
stress	NULL
)	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

The	NULL
adherence/contact	NULL
of	NULL
SS	NULL
RBC	NULL
to	NULL
endothelial	NULL
cells	NULL
helps	NULL
in	NULL
localizing	NULL
the	NULL
oxidant	NULL
stimulus	NULL
to	NULL
the	NULL
cell	NULL
surface	NULL
to	NULL
initiate	NULL
cellular	NULL
signaling	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
of	NULL
the	NULL
cellular	NULL
signaling	NULL
,	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
occurs	NULL
in	NULL
HUVEC	NULL
leading	NULL
to	NULL
the	NULL
binding	NULL
of	NULL
activated	NULL
NF-kB	NULL
to	NULL
the	NULL
consensus	NULL
sites	NULL
in	NULL
the	NULL
regulatory	NULL
regions	NULL
of	NULL
DNA	NULL
for	NULL
several	NULL
genes	NULL
including	NULL
a	NULL
subset	NULL
of	NULL
CAMs	NULL
,	NULL
thereby	NULL
bringing	NULL
about	NULL
the	NULL
cell-surface	NULL
expression	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
CAMs	NULL
,	NULL
ICAM-1	NULL
,	NULL
E-selectin	NULL
,	NULL
and	NULL
VCAM-1	NULL
.	NULL

The	NULL
increased	NULL
expression	NULL
of	NULL
CAMs	NULL
in	NULL
response	NULL
to	NULL
oxidative	NULL
stress	NULL
is	NULL
not	NULL
unique	NULL
to	NULL
the	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
to	NULL
endothelium	NULL
,	NULL
but	NULL
can	NULL
occur	NULL
in	NULL
response	NULL
to	NULL
endotoxins	NULL
or	NULL
hypoxia	NULL
,	NULL
conditions	NULL
eg	NULL
,	NULL
bacterial	NULL
infection	NULL
and	NULL
tissue	NULL
hypox-emia	NULL
commonly	NULL
associated	NULL
with	NULL
SCD	NULL
.	NULL

The	NULL
increased	NULL
surface	NULL
expression	NULL
of	NULL
VCAM-1	NULL
in	NULL
endothelial	NULL
cells	NULL
,	NULL
as	NULL
a	NULL
result	NULL
of	NULL
the	NULL
adherence	NULL
of	NULL
SS	NULL
RBC	NULL
,	NULL
will	NULL
promote	NULL
additional	NULL
adherence	NULL
of	NULL
SS	NULL
reticulocytes	NULL
expressing	NULL
the	NULL
«	NULL
,	NULL
B	NULL
;	NULL
ligand	NULL
via	NULL
VCAM-1	NULL
.	NULL

These	NULL
CAMs	NULL
also	NULL
act	NULL
as	NULL
receptors/adhesive	NULL
agents	NULL
for	NULL
PMN	NULL
and	NULL
monocytes	NULL
expressing	NULL
the	NULL
appropriate	NULL
counter-receptors	NULL
.	NULL

The	NULL
adhesion	NULL
of	NULL
PMN	NULL
and	NULL
monocytes	NULL
at	NULL
the	NULL
sites	NULL
of	NULL
thrombotic	NULL
occlusion	NULL
by	NULL
SS	NULL
RBC	NULL
or	NULL
in	NULL
small	NULL
venules	NULL
in	NULL
which	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
is	NULL
maximal®	NULL
may	NULL
cause	NULL
further	NULL
obstruction	NULL
in	NULL
the	NULL
flow	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3934	NULL
of	NULL
blood	NULL
and	NULL
promote	NULL
vasoocelusion	NULL
.	NULL

Furthermore	NULL
,	NULL
our	NULL
studies	NULL
show	NULL
that	NULL
the	NULL
cellular	NULL
oxidant	NULL
stress	NULL
,	NULL
generated	NULL
by	NULL
the	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
to	NULL
HUVEC	NULL
brings	NULL
about	NULL
increased	NULL
migration	NULL
of	NULL
monocytes	NULL
across	NULL
the	NULL
endothelial	NULL
cell	NULL
monolayer	NULL
.	NULL

In	NULL
SCD	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
accumulation	NULL
of	NULL
monocytes	NULL
may	NULL
participate	NULL
in	NULL
the	NULL
stroke	NULL
syndrome	NULL
in	NULL
which	NULL
arterial	NULL
narrowing	NULL
and	NULL
thrombosis	NULL
resemble	NULL
the	NULL
events	NULL
observed	NULL
in	NULL
cerebrovascular	NULL
atherosclero-sis	NULL
.	NULL

Thus	NULL
the	NULL
abnormal	NULL
adherence	NULL
of	NULL
SS	NULL
RBC	NULL
to	NULL
endothelial	NULL
cells	NULL
from	NULL
large	NULL
vessels	NULL
can	NULL
generate	NULL
enhanced	NULL
oxidant	NULL
stress	NULL
leading	NULL
to	NULL
increased	NULL
adhesion	NULL
and	NULL
diapedesis	NULL
of	NULL
monocytes	NULL
,	NULL
as	NULL
well	NULL
as	NULL
heightened	NULL
adherence	NULL
of	NULL
SS	NULL
reticulocytes	NULL
.	NULL

Although	NULL
the	NULL
studies	NULL
presented	NULL
have	NULL
been	NULL
conducted	NULL
in	NULL
endothelial	NULL
cells	NULL
derived	NULL
from	NULL
large	NULL
vessels	NULL
,	NULL
we	NULL
suspect	NULL
that	NULL
a	NULL
similar	NULL
phenomenon	NULL
may	NULL
also	NULL
occur	NULL
in	NULL
microvascular	NULL
endothelium	NULL
in	NULL
which	NULL
the	NULL
adhesion	NULL
of	NULL
SS	NULL
RBC	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
thrombospondin	NULL
.	NULL

Such	NULL
studies	NULL
should	NULL
provide	NULL
an	NULL
insight	NULL
into	NULL
the	NULL
process	NULL
of	NULL
obstruction	NULL
or	NULL
intermittent	NULL
flow	NULL
of	NULL
blood	NULL
observed	NULL
in	NULL
the	NULL
microcirculation	NULL
of	NULL
patients	NULL
with	NULL
SCD	NULL
.	NULL

Further	NULL
studies	NULL
should	NULL
be	NULL
performed	NULL
to	NULL
determine	NULL
whether	NULL
density-fractionated	NULL
less-dense	NULL
(	NULL
enriched	NULL
in	NULL
reticulocytes	NULL
)	NULL
,	NULL
or	NULL
most-dense	NULL
fraction	NULL
of	NULL
sickle	NULL
blood	NULL
,	NULL
with	NULL
and	NULL
without	NULL
deoxygenation	NULL
,	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
cellular	NULL
oxidant	NULL
stress	NULL
and	NULL
hence	NULL
activation	NULL
of	NULL
endothelium	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
deeply	NULL
appreciate	NULL
the	NULL
assistance	NULL
of	NULL
Pat	NULL
Corley	NULL
,	NULL
RN	NULL
,	NULL
for	NULL
obtaining	NULL
the	NULL
blood	NULL
specimens	NULL
from	NULL
patients	NULL
.	NULL

The	NULL
assistance	NULL
of	NULL
Anne	NULL
Erwin	NULL
,	NULL
MS	NULL
,	NULL
in	NULL
technical	NULL
editing	NULL
of	NULL
the	NULL
manuscript	NULL
is	NULL
greatly	NULL
appreciated	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Harlan	NULL
JM	NULL
,	NULL
Winn	NULL
RK	NULL
,	NULL
Veeder	NULL
NB	NULL
,	NULL
Doerschuk	NULL
CM	NULL
,	NULL
Rice	NULL
CL	NULL
:	NULL
In	NULL
vivo	NULL
models	NULL
of	NULL
leukocytes	NULL
adherence	NULL
to	NULL
endothelium	NULL
,	NULL
in	NULL
Harlan	NULL
JM	NULL
,	NULL
Liu	NULL
DY	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Adhesion-Its	NULL
Role	NULL
in	NULL
Inflammatory	NULL
Disease	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Freeman	NULL
,	NULL
1992	NULL
,	NULL
p	NULL
117	NULL
2	NULL
.	NULL

Hebbel	NULL
RP	NULL
,	NULL
Yamada	NULL
O	NULL
,	NULL
Moldow	NULL
CF	NULL
,	NULL
Jacob	NULL
HS	NULL
,	NULL
White	NULL
JG	NULL
,	NULL
Eaton	NULL
JW	NULL
:	NULL
Abnormal	NULL
adherence	NULL
of	NULL
sickle	NULL
erythrocytes	NULL
to	NULL
cultured	NULL
vascular	NULL
endothelium	NULL
:	NULL
Possible	NULL
mechanism	NULL
for	NULL
microvascular	NULL
occlusion	NULL
in	NULL
sickle	NULL
cell	NULL
disease	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
65:1	NULL
54	NULL
,	NULL
1980	NULL
3	NULL
.	NULL

Barabino	NULL
GA	NULL
,	NULL
McIntire	NULL
LV	NULL
,	NULL
Eskin	NULL
SG	NULL
,	NULL
Sears	NULL
DA	NULL
,	NULL
Udden	NULL
M	NULL
:	NULL
Endothelial	NULL
cell	NULL
interactions	NULL
with	NULL
sickle	NULL
cell	NULL
,	NULL
sickle	NULL
trait	NULL
,	NULL
mechanically	NULL
injured	NULL
,	NULL
and	NULL
normal	NULL
erythrocytes	NULL
under	NULL
controlled	NULL
flow	NULL
.	NULL

Blood	NULL
70:152	NULL
,	NULL
1987	NULL
4	NULL
.	NULL

Kaul	NULL
DK	NULL
,	NULL
Fabry	NULL
ME	NULL
,	NULL
Nagel	NULL
RL	NULL
:	NULL
Microvascular	NULL
sites	NULL
and	NULL
characteristics	NULL
of	NULL
sickle	NULL
cell	NULL
adhesion	NULL
to	NULL
vascular	NULL
endothelium	NULL
in	NULL
shear	NULL
flow	NULL
conditions	NULL
:	NULL
Pathophysiological	NULL
implications	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:3356	NULL
,	NULL
1989	NULL
5	NULL
.	NULL

Hebbel	NULL
RP	NULL
,	NULL
Mohandas	NULL
N	NULL
:	NULL
Sickle	NULL
Cell	NULL
Adherence	NULL
,	NULL
in	NULL
Embury	NULL
SH	NULL
,	NULL
Hebbel	NULL
RP	NULL
,	NULL
Mohandas	NULL
N	NULL
,	NULL
Steinberg	NULL
MH	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Sickle	NULL
Cell	NULL
Discase-Basic	NULL
Principles	NULL
and	NULL
Clinical	NULL
Practice	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Raven	NULL
,	NULL
1994	NULL
,	NULL
p	NULL
217	NULL
6	NULL
.	NULL

Hebbel	NULL
RP	NULL
,	NULL
Boogaerts	NULL
MA	NULL
,	NULL
Eaton	NULL
JW	NULL
,	NULL
Steinberg	NULL
MH	NULL
:	NULL
Erythrocyte	NULL
adherence	NULL
to	NULL
endothelium	NULL
in	NULL
sickle-cell	NULL
anemia	NULL
.	NULL

A	NULL
possible	NULL
determinant	NULL
of	NULL
disease	NULL
severity	NULL
.	NULL

N	NULL
Eng	NULL
!	NULL

J	NULL
Med	NULL
302:992	NULL
,	NULL
1980	NULL
7	NULL
.	NULL

Francis	NULL
RB	NULL
,	NULL
Jr.	NULL
,	NULL
Johnson	NULL
CS	NULL
:	NULL
Vascular	NULL
occlusion	NULL
in	NULL
sickle	NULL
cell	NULL
disease	NULL
:	NULL
Current	NULL
concepts	NULL
and	NULL
unanswered	NULL
questions	NULL
.	NULL

Blood	NULL
77:1405	NULL
,	NULL
1991	NULL
8	NULL
.	NULL

Kaul	NULL
DK	NULL
,	NULL
Fabry	NULL
ME	NULL
,	NULL
Nagel	NULL
RL	NULL
:	NULL
The	NULL
pathophysiology	NULL
of	NULL
vascular	NULL
obstruction	NULL
in	NULL
the	NULL
sickle	NULL
syndromes	NULL
.	NULL

Blood	NULL
Rev	NULL
10:29	NULL
,	NULL
1996	NULL
9	NULL
.	NULL

Solovey	NULL
A	NULL
,	NULL
Lin	NULL
Y	NULL
,	NULL
Browne	NULL
P	NULL
,	NULL
Choong	NULL
S	NULL
,	NULL
Wayner	NULL
E	NULL
,	NULL
Hebbel	NULL
RP	NULL
:	NULL
Circulating	NULL
activated	NULL
endothelial	NULL
cells	NULL
in	NULL
sickle	NULL
cell	NULL
anemia	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
337:1584	NULL
,	NULL
1997	NULL
SULTANA	NULL
ET	NULL
AL	NULL
10	NULL
.	NULL

Phelan	NULL
M	NULL
,	NULL
Perrine	NULL
SP	NULL
,	NULL
Brauer	NULL
M	NULL
,	NULL
Faller	NULL
DV	NULL
:	NULL
Sickle	NULL
erythrocytes	NULL
,	NULL
after	NULL
sickling	NULL
,	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
endothelin-1	NULL
gene	NULL
and	NULL
protein	NULL
in	NULL
human	NULL
endothelial	NULL
cells	NULL
in	NULL
culture	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
96:1145	NULL
,	NULL
1995	NULL
11	NULL
.	NULL

Faller	NULL
DV	NULL
:	NULL
Vascular	NULL
Modulation	NULL
,	NULL
in	NULL
Embury	NULL
SH	NULL
,	NULL
Hebbel	NULL
RP	NULL
,	NULL
Mohandas	NULL
N	NULL
,	NULL
Steinberg	NULL
MH	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Sickle	NULL
Cell	NULL
Disease-Basic	NULL
Principles	NULL
and	NULL
Clinical	NULL
Practice	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Raven	NULL
,	NULL
1994	NULL
,	NULL
p	NULL
235	NULL
12	NULL
.	NULL

Hebbel	NULL
RP	NULL
,	NULL
Eaton	NULL
JW	NULL
,	NULL
Balasingam	NULL
M	NULL
,	NULL
Steinberg	NULL
MH	NULL
:	NULL
Spontaneous	NULL
oxygen	NULL
radical	NULL
generation	NULL
by	NULL
sickle	NULL
erythrocytes	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
70:1253	NULL
,	NULL
1982	NULL
13	NULL
.	NULL

Hebbel	NULL
RP	NULL
,	NULL
Morgan	NULL
WT	NULL
,	NULL
Eaton	NULL
JW	NULL
,	NULL
Hedlund	NULL
BE	NULL
:	NULL
Accelerated	NULL
autoxidation	NULL
and	NULL
heme	NULL
loss	NULL
due	NULL
to	NULL
instability	NULL
of	NULL
sickle	NULL
hemoglobin	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:237	NULL
,	NULL
1988	NULL
14	NULL
.	NULL

Claster	NULL
S	NULL
,	NULL
Chiu	NULL
DT	NULL
,	NULL
Quintanilha	NULL
A	NULL
,	NULL
Lubin	NULL
B	NULL
:	NULL
Neutrophils	NULL
mediate	NULL
lipid	NULL
peroxidation	NULL
in	NULL
human	NULL
red	NULL
cells	NULL
.	NULL

Blood	NULL
64:1079	NULL
,	NULL
1984	NULL
15	NULL
.	NULL

Hebbel	NULL
RP	NULL
:	NULL
Beyond	NULL
hemoglobin	NULL
polymerization	NULL
:	NULL
The	NULL
red	NULL
blood	NULL
cell	NULL
membrane	NULL
and	NULL
sickle	NULL
disease	NULL
pathophysiology	NULL
.	NULL

Blood	NULL
77:214	NULL
,	NULL
1991	NULL
16	NULL
.	NULL

Bacuerle	NULL
PA	NULL
,	NULL
Henkel	NULL
T	NULL
:	NULL
Function	NULL
and	NULL
activation	NULL
of	NULL
NF-kappa	NULL
B	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
12:141	NULL
,	NULL
1994	NULL
17	NULL
.	NULL

Schreck	NULL
R	NULL
,	NULL
Ricber	NULL
P	NULL
,	NULL
Bacuerle	NULL
PA	NULL
:	NULL
Reactive	NULL
oxygen	NULL
intermediates	NULL
as	NULL
apparently	NULL
widely	NULL
used	NULL
messengers	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-kappa	NULL
B	NULL
transcription	NULL
factor	NULL
and	NULL
HIV-1	NULL
.	NULL

EMBO	NULL
J	NULL
10:2247	NULL
,	NULL
1991	NULL
18	NULL
.	NULL

Marui	NULL
N	NULL
,	NULL
Offermann	NULL
MK	NULL
,	NULL
Swerlick	NULL
R	NULL
,	NULL
Kunsch	NULL
C	NULL
,	NULL
Rosen	NULL
CA	NULL
,	NULL
Abmad	NULL
M	NULL
,	NULL
Alexander	NULL
RW	NULL
,	NULL
Medford	NULL
RM	NULL
:	NULL
Vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
VCAM-1	NULL
)	NULL
gene	NULL
transcription	NULL
and	NULL
expression	NULL
are	NULL
regulated	NULL
through	NULL
an	NULL
antioxidant-sensitive	NULL
mechanism	NULL
in	NULL
human	NULL
vascular	NULL
endothelial	NULL
cells	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
92:1866	NULL
,	NULL
1993	NULL
19	NULL
.	NULL

Swerlick	NULL
RA	NULL
,	NULL
Eckman	NULL
JR	NULL
,	NULL
Kumar	NULL
A	NULL
,	NULL
Jeitler	NULL
M	NULL
,	NULL
Wick	NULL
TM	NULL
:	NULL
Alpha	NULL
4	NULL
beta	NULL
l-integrin	NULL
expression	NULL
on	NULL
sickle	NULL
reticulocytes	NULL
:	NULL
Vascular	NULL
cell	NULL
adhesion	NULL
molecule-1-dependent	NULL
binding	NULL
to	NULL
endothelium	NULL
.	NULL

Blood	NULL
82	NULL
:	NULL
1891	NULL
,	NULL
1993	NULL
20	NULL
.	NULL

Gee	NULL
BE	NULL
,	NULL
Platt	NULL
OS	NULL
:	NULL
Sickle	NULL
reticulocytes	NULL
adhere	NULL
to	NULL
VCAM-1	NULL
.	NULL

Blood	NULL
85:268	NULL
,	NULL
1995	NULL
21	NULL
.	NULL

Wautier	NULL
JL	NULL
,	NULL
Wautier	NULL
MP	NULL
,	NULL
Schmidt	NULL
AM	NULL
,	NULL
Anderson	NULL
GM	NULL
,	NULL
Hori	NULL
O	NULL
,	NULL
Zoukourian	NULL
C	NULL
,	NULL
Capron	NULL
L	NULL
,	NULL
Chappey	NULL
O	NULL
,	NULL
Yan	NULL
SD	NULL
,	NULL
Brett	NULL
J	NULL
:	NULL
Advanced	NULL
glycation	NULL
end	NULL
products	NULL
(	NULL
AGEs	NULL
)	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
diabetic	NULL
erythrocytes	NULL
bind	NULL
to	NULL
the	NULL
vessel	NULL
wall	NULL
via	NULL
a	NULL
specific	NULL
receptor	NULL
inducing	NULL
oxidant	NULL
stress	NULL
in	NULL
the	NULL
vasculature	NULL
:	NULL
A	NULL
link	NULL
between	NULL
surface-associated	NULL
AGEs	NULL
and	NULL
diabetic	NULL
complications	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
91:7742	NULL
,	NULL
1994	NULL
22	NULL
.	NULL

Jaffe	NULL
S	NULL
,	NULL
Oliver	NULL
PD	NULL
,	NULL
Faroogui	NULL
SM	NULL
,	NULL
Novak	NULL
PL	NULL
,	NULL
Sorgente	NULL
N	NULL
,	NULL
Kalra	NULL
VK	NULL
:	NULL
Separation	NULL
of	NULL
luminal	NULL
and	NULL
abluminal	NULL
membrane	NULL
enriched	NULL
domains	NULL
from	NULL
cultured	NULL
bovine	NULL
aortic	NULL
endothelial	NULL
cells	NULL
:	NULL
Monoclonal	NULL
antibodies	NULL
specific	NULL
for	NULL
endothelial	NULL
cell	NULL
plasma	NULL
membranes	NULL
.	NULL

Biochim	NULL
Biophys	NULL
Acta	NULL
898:37	NULL
,	NULL
1987	NULL
23	NULL
.	NULL

Kalra	NULL
VK	NULL
,	NULL
Banerjee	NULL
R	NULL
,	NULL
Sorgente	NULL
N	NULL
:	NULL
Heterotypic	NULL
and	NULL
homotypic	NULL
cell-cell	NULL
adhesion	NULL
molecules	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

Biotechnol	NULL
Appl	NULL
Biochem	NULL
12:579	NULL
,	NULL
1990	NULL
24	NULL
.	NULL

Albelda	NULL
SM	NULL
,	NULL
Muller	NULL
WA	NULL
,	NULL
Buck	NULL
CA	NULL
,	NULL
Newman	NULL
PJ	NULL
:	NULL
Molecular	NULL
and	NULL
cellular	NULL
properties	NULL
of	NULL
PECAM-1	NULL
(	NULL
endoCAM/CD31	NULL
)	NULL
:	NULL
A	NULL
novel	NULL
vascular	NULL
cell-cell	NULL
adhesion	NULL
molecule	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
114:1059	NULL
,	NULL
1991	NULL
25	NULL
.	NULL

Newman	NULL
PJ	NULL
,	NULL
Hillery	NULL
CA	NULL
,	NULL
Albrecht	NULL
R	NULL
,	NULL
Parise	NULL
LV	NULL
,	NULL
Berndt	NULL
MC	NULL
,	NULL
Mazurov	NULL
AV	NULL
,	NULL
Dunlop	NULL
LC	NULL
,	NULL
Zhang	NULL
J	NULL
,	NULL
Rittenhouse	NULL
SE	NULL
:	NULL
Activation-dependent	NULL
changes	NULL
in	NULL
human	NULL
platelet	NULL
PECAM-1	NULL
:	NULL
Phosphorylation	NULL
,	NULL
cytoskeletal	NULL
association	NULL
,	NULL
and	NULL
surface	NULL
membrane	NULL
redistribution	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
119:239	NULL
,	NULL
1992	NULL
26	NULL
.	NULL

Muller	NULL
WA	NULL
,	NULL
Berman	NULL
ME	NULL
,	NULL
Newman	NULL
PJ	NULL
,	NULL
DeLisser	NULL
HM	NULL
,	NULL
Albelda	NULL
SM	NULL
:	NULL
A	NULL
heterophilic	NULL
adhesion	NULL
mechanism	NULL
for	NULL
platelet/endothelial	NULL
cell	NULL
adhesion	NULL
molecule	NULL
1	NULL
(	NULL
CD31	NULL
)	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
175:1401	NULL
,	NULL
1992	NULL
27	NULL
.	NULL

Vaporciyan	NULL
AA	NULL
,	NULL
DeLisser	NULL
HM	NULL
,	NULL
Yan	NULL
HC	NULL
,	NULL
Mendiguren	NULL
II	NULL
,	NULL
Thom	NULL
SR	NULL
,	NULL
Jones	NULL
ML	NULL
,	NULL
Ward	NULL
PA	NULL
,	NULL
Albelda	NULL
SM	NULL
:	NULL
Involvement	NULL
of	NULL
platelet-endothelial	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
in	NULL
neutrophil	NULL
recruitment	NULL
in	NULL
vivo	NULL
.	NULL

Science	NULL
262:1580	NULL
,	NULL
1993	NULL
28	NULL
.	NULL

Kalra	NULL
VK	NULL
,	NULL
Sikka	NULL
SC	NULL
,	NULL
Sethi	NULL
GS	NULL
:	NULL
Transport	NULL
of	NULL
amino	NULL
acids	NULL
in	NULL
gamma-glutamyl	NULL
]	NULL
transpeptidase-implanted	NULL
human	NULL
erythrocytes	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
256:5567	NULL
,	NULL
1981	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

SS	NULL
RBC-INDUCED	NULL
OXIDANT	NULL
STRESS	NULL
IN	NULL
ENDOTHELIUM	NULL
29	NULL
.	NULL

Kalra	NULL
VK	NULL
,	NULL
Ying	NULL
Y	NULL
,	NULL
Deemer	NULL
K	NULL
,	NULL
Natarajan	NULL
R	NULL
,	NULL
Nadler	NULL
JL	NULL
,	NULL
Coates	NULL
TD	NULL
:	NULL
Mechanism	NULL
of	NULL
cigarette	NULL
smoke	NULL
condensate	NULL
induced	NULL
adhesion	NULL
of	NULL
human	NULL
monocytes	NULL
to	NULL
cultured	NULL
endothelial	NULL
cells	NULL
.	NULL

J	NULL
Cell	NULL
Physiol	NULL
160:154	NULL
,	NULL
1994	NULL
30	NULL
.	NULL

Languino	NULL
LR	NULL
,	NULL
Duperray	NULL
A	NULL
,	NULL
Joganic	NULL
KJ	NULL
,	NULL
Fornaro	NULL
M	NULL
,	NULL
Thornton	NULL
GB	NULL
,	NULL
Altieri	NULL
DC	NULL
:	NULL
Regulation	NULL
of	NULL
leukocyte-endothelium	NULL
interaction	NULL
and	NULL
leukocyte	NULL
transendothelial	NULL
migration	NULL
by	NULL
intercellular	NULL
adhesion	NULL
molecule	NULL
1-fibrinogen	NULL
recognition	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
92:1	NULL
505	NULL
,	NULL
1995	NULL
31	NULL
.	NULL

Shen	NULL
Y	NULL
,	NULL
Rattan	NULL
V	NULL
,	NULL
Sultana	NULL
C	NULL
,	NULL
Kalra	NULL
VK	NULL
:	NULL
Cigarette	NULL
smoke	NULL
condensate-induced	NULL
adhesion	NULL
molecule	NULL
expression	NULL
and	NULL
transendothelial	NULL
migration	NULL
of	NULL
monocytes	NULL
.	NULL

Am	NULL
J	NULL
Physiol	NULL
270	NULL
:	NULL
H1624	NULL
,	NULL
1996	NULL
32	NULL
.	NULL

Sporn	NULL
LA	NULL
,	NULL
Marder	NULL
VJ	NULL
,	NULL
Wagner	NULL
DD	NULL
:	NULL
Inducible	NULL
secretion	NULL
of	NULL
large	NULL
,	NULL
biologically	NULL
potent	NULL
von	NULL
Willebrand	NULL
factor	NULL
multimers	NULL
.	NULL

Cell	NULL
46:185	NULL
,	NULL
1986	NULL
33	NULL
.	NULL

Tsai	NULL
HM	NULL
,	NULL
Nagel	NULL
RL	NULL
,	NULL
Hatcher	NULL
VB	NULL
,	NULL
Sussman	NULL
II	NULL
:	NULL
Multimeric	NULL
composition	NULL
of	NULL
endothelial	NULL
cell-derived	NULL
von	NULL
Willebrand	NULL
factor	NULL
.	NULL

Blood	NULL
73:2074	NULL
,	NULL
1989	NULL
34	NULL
.	NULL

Kunisaki	NULL
M	NULL
,	NULL
Umeda	NULL
F	NULL
,	NULL
Yamauchi	NULL
T	NULL
,	NULL
Masakado	NULL
M	NULL
,	NULL
Nawata	NULL
H	NULL
:	NULL
;	NULL
High	NULL
glucose	NULL
reduces	NULL
specific	NULL
binding	NULL
for	NULL
D-alpha-tocopherol	NULL
in	NULL
cultured	NULL
aortic	NULL
endothelial	NULL
cells	NULL
.	NULL

Diabetes	NULL
42:1138	NULL
,	NULL
1993	NULL
35	NULL
.	NULL

Rajeswari	NULL
P	NULL
,	NULL
Natarajan	NULL
R	NULL
,	NULL
Nadler	NULL
JL	NULL
,	NULL
Kumar	NULL
D	NULL
,	NULL
Kalra	NULL
VK	NULL
:	NULL
Glucose	NULL
induces	NULL
lipid	NULL
peroxidation	NULL
and	NULL
inactivation	NULL
of	NULL
membrane-associated	NULL
ion-transport	NULL
enzymes	NULL
in	NULL
human	NULL
erythrocytes	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
.	NULL

J	NULL
Cell	NULL
Physiol	NULL
149:100	NULL
,	NULL
1991	NULL
36	NULL
.	NULL

Wali	NULL
RK	NULL
,	NULL
Jaffe	NULL
S	NULL
,	NULL
Kumar	NULL
D	NULL
,	NULL
Kalra	NULL
VK	NULL
:	NULL
Alterations	NULL
in	NULL
organization	NULL
of	NULL
phospholipids	NULL
in	NULL
erythrocytes	NULL
as	NULL
factor	NULL
in	NULL
adherence	NULL
to	NULL
endothelial	NULL
cells	NULL
in	NULL
diabetes	NULL
mellitus	NULL
.	NULL

Diabetes	NULL
37:104	NULL
,	NULL
1988	NULL
37	NULL
.	NULL

Sultana	NULL
C	NULL
,	NULL
Shen	NULL
Y	NULL
,	NULL
Rattan	NULL
V	NULL
,	NULL
Kalra	NULL
VK	NULL
:	NULL
Lipoxygenase	NULL
metabolites	NULL
induced	NULL
expression	NULL
of	NULL
adhesion	NULL
molecules	NULL
and	NULL
transendothelial	NULL
migration	NULL
of	NULL
monocyte-like	NULL
HL-60	NULL
cells	NULL
is	NULL
linked	NULL
to	NULL
protein	NULL
kinase	NULL
C	NULL
activation	NULL
.	NULL

J	NULL
Cell	NULL
Physiol	NULL
167:477	NULL
,	NULL
1996	NULL
38	NULL
.	NULL

Kazakoff	NULL
PW	NULL
,	NULL
McGuire	NULL
TR	NULL
,	NULL
Hoie	NULL
EB	NULL
,	NULL
Cano	NULL
M	NULL
,	NULL
Iversen	NULL
PL	NULL
:	NULL
An	NULL
in	NULL
vitro	NULL
model	NULL
for	NULL
endothelial	NULL
permeability	NULL
:	NULL
Assessment	NULL
of	NULL
monolayer	NULL
integrity	NULL
.	NULL

In	NULL
Vitro	NULL
Cell	NULL
Dev	NULL
Biol	NULL
Anim	NULL
31:846	NULL
,	NULL
1995	NULL
39	NULL
.	NULL

Wick	NULL
TM	NULL
,	NULL
Moake	NULL
JL	NULL
,	NULL
Udden	NULL
MM	NULL
,	NULL
McIntire	NULL
LV	NULL
:	NULL
Unusually	NULL
large	NULL
von	NULL
Willebrand	NULL
factor	NULL
multimers	NULL
preferentially	NULL
promote	NULL
young	NULL
sickle	NULL
and	NULL
nonsickle	NULL
erythrocyte	NULL
adhesion	NULL
to	NULL
endothelial	NULL
cells	NULL
.	NULL

Am	NULL
J	NULL
Hematol	NULL
42:284	NULL
,	NULL
1993	NULL
40	NULL
.	NULL

Yan	NULL
SD	NULL
,	NULL
Schmidt	NULL
AM	NULL
,	NULL
Anderson	NULL
GM	NULL
,	NULL
Zhang	NULL
J	NULL
,	NULL
Brett	NULL
J	NULL
,	NULL
Zou	NULL
YS	NULL
,	NULL
Pinsky	NULL
D	NULL
,	NULL
Stern	NULL
D	NULL
:	NULL
Enhanced	NULL
cellular	NULL
oxidant	NULL
stress	NULL
by	NULL
the	NULL
interaction	NULL
of	NULL
advanced	NULL
glycation	NULL
end	NULL
products	NULL
with	NULL
their	NULL
receptors/binding	NULL
proteins	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
269:9889	NULL
,	NULL
1994	NULL
41	NULL
.	NULL

Lander	NULL
HM	NULL
,	NULL
Ogiste	NULL
JS	NULL
,	NULL
Teng	NULL
KK	NULL
,	NULL
Novogrodsky	NULL
A	NULL
:	NULL
p21ras	NULL
as	NULL
a	NULL
common	NULL
signaling	NULL
target	NULL
of	NULL
reactive	NULL
free	NULL
radicals	NULL
and	NULL
cellular	NULL
redox	NULL
stress	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:21195	NULL
,	NULL
1995	NULL
42	NULL
.	NULL

Linassier	NULL
C	NULL
,	NULL
Pierre	NULL
M	NULL
,	NULL
Le	NULL
Pecq	NULL
JB	NULL
,	NULL
Pierre	NULL
J	NULL
:	NULL
Mechanisms	NULL
of	NULL
action	NULL
in	NULL
NIH-3T3	NULL
cells	NULL
of	NULL
genistein	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
EGF	NULL
receptor	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
.	NULL

Biochem	NULL
Pharmacol	NULL
39:187	NULL
,	NULL
1990	NULL
43	NULL
.	NULL

Pan	NULL
Z	NULL
,	NULL
Kravchenko	NULL
VV	NULL
,	NULL
Ye	NULL
RD	NULL
:	NULL
Platelet-activating	NULL
factor	NULL
stimulates	NULL
transcription	NULL
of	NULL
the	NULL
heparin-binding	NULL
epidermal	NULL
growth	NULL
factor-like	NULL
growth	NULL
factor	NULL
in	NULL
monocytes	NULL
.	NULL

Correlation	NULL
with	NULL
an	NULL
increased	NULL
kappa	NULL
B	NULL
binding	NULL
activity	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:7787	NULL
,	NULL
1995	NULL
44	NULL
.	NULL

Rattan	NULL
V	NULL
,	NULL
Sultana	NULL
C	NULL
,	NULL
Shen	NULL
Y	NULL
,	NULL
Kalra	NULL
VK	NULL
:	NULL
Oxidant	NULL
stress-induced	NULL
transendothelial	NULL
migration	NULL
of	NULL
monocytes	NULL
is	NULL
linked	NULL
to	NULL
phosphorylation	NULL
of	NULL
PECAM-1	NULL
.	NULL

Am	NULL
J	NULL
Physiol	NULL
273	NULL
:	NULL
B453	NULL
,	NULL
1997	NULL
3935	NULL
45	NULL
.	NULL

Suttorp	NULL
N	NULL
,	NULL
Toepfer	NULL
W	NULL
,	NULL
Roka	NULL
L	NULL
:	NULL
Antioxidant	NULL
defense	NULL
mechanisms	NULL
of	NULL
endothelial	NULL
cells	NULL
:	NULL
Glutathione	NULL
redox	NULL
cycle	NULL
versus	NULL
catalase	NULL
.	NULL

Am	NULL
J	NULL
Physiol	NULL
251	NULL
:	NULL
C671	NULL
,	NULL
1986	NULL
46	NULL
.	NULL

Toullec	NULL
D	NULL
,	NULL
Pianetti	NULL
P	NULL
,	NULL
Coste	NULL
H	NULL
,	NULL
Bellevergue	NULL
P	NULL
,	NULL
Grand-Perret	NULL
T	NULL
,	NULL
Ajakane	NULL
M	NULL
,	NULL
Baudet	NULL
V	NULL
,	NULL
Boissin	NULL
P	NULL
,	NULL
Boursier	NULL
E	NULL
,	NULL
Loriolle	NULL
F	NULL
:	NULL
The	NULL
bisindolyl-maleimide	NULL
GF	NULL
109203X	NULL
is	NULL
a	NULL
potent	NULL
and	NULL
selective	NULL
inhibitor	NULL
of	NULL
protein	NULL
kinase	NULL
C.	NULL
J	NULL
Biol	NULL
Chem	NULL
266:15771	NULL
,	NULL
1991	NULL
47	NULL
.	NULL

Ishihara	NULL
H	NULL
,	NULL
Martin	NULL
BL	NULL
,	NULL
Brautigan	NULL
DL	NULL
,	NULL
Karaki	NULL
H	NULL
,	NULL
Ozaki	NULL
H	NULL
,	NULL
Kato	NULL
Y	NULL
,	NULL
Fusetani	NULL
N	NULL
,	NULL
Watabe	NULL
S	NULL
,	NULL
Hashimoto	NULL
K	NULL
,	NULL
Uemura	NULL
D	NULL
:	NULL
Calyculin	NULL
A	NULL
and	NULL
okadaic	NULL
acid	NULL
:	NULL
Inhibitors	NULL
of	NULL
protein	NULL
phosphatase	NULL
activity	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
159:871	NULL
,	NULL
1989	NULL
48	NULL
.	NULL

Uedono	NULL
Y	NULL
,	NULL
Takeyama	NULL
N	NULL
,	NULL
Yamagami	NULL
K	NULL
,	NULL
Tanaka	NULL
T	NULL
:	NULL
Lipopolysac-charide-mediated	NULL
hepatic	NULL
glutathione	NULL
depletion	NULL
and	NULL
progressive	NULL
mito-chondrial	NULL
damage	NULL
in	NULL
mice	NULL
:	NULL
Protective	NULL
effect	NULL
of	NULL
glutathione	NULL
monoethyl	NULL
ester	NULL
.	NULL

J	NULL
Surg	NULL
Res	NULL
70:49	NULL
,	NULL
1997	NULL
49	NULL
.	NULL

Shi	NULL
WX	NULL
,	NULL
Bunney	NULL
BS	NULL
:	NULL
Roles	NULL
of	NULL
intracellular	NULL
cAMP	NULL
and	NULL
protein	NULL
kinase	NULL
A	NULL
in	NULL
the	NULL
actions	NULL
of	NULL
dopamine	NULL
and	NULL
neurotensin	NULL
on	NULL
midbrain	NULL
dopamine	NULL
neurons	NULL
.	NULL

J	NULL
Neurosci	NULL
12:2433	NULL
,	NULL
1992	NULL
50	NULL
.	NULL

Wong	NULL
WY	NULL
,	NULL
Powars	NULL
DR	NULL
,	NULL
Chan	NULL
L	NULL
,	NULL
Hiti	NULL
A	NULL
,	NULL
Johnson	NULL
C	NULL
,	NULL
Overturf	NULL
G	NULL
:	NULL
Polysaccharide	NULL
encapsulated	NULL
bacterial	NULL
infection	NULL
in	NULL
sickle	NULL
cell	NULL
anemia	NULL
:	NULL
A	NULL
thirty	NULL
year	NULL
epidemiologic	NULL
experience	NULL
.	NULL

Am	NULL
J	NULL
Hematol	NULL
39:176	NULL
,	NULL
1992	NULL
51	NULL
.	NULL

Platt	NULL
OS	NULL
,	NULL
Thorington	NULL
BD	NULL
,	NULL
Brambilla	NULL
DJ	NULL
,	NULL
Milner	NULL
PF	NULL
,	NULL
Rosse	NULL
WF	NULL
,	NULL
Vichinsky	NULL
E	NULL
,	NULL
Kinney	NULL
TR	NULL
:	NULL
Pain	NULL
in	NULL
sickle	NULL
cell	NULL
disease	NULL
.	NULL

Rates	NULL
and	NULL
risk	NULL
factors	NULL
[	NULL
see	NULL
comments	NULL
]	NULL
.	NULL

N	NULL
Engl	NULL
!	NULL

J	NULL
Med	NULL
325:11	NULL
,	NULL
1991	NULL
52	NULL
.	NULL

Buchanan	NULL
GR	NULL
:	NULL
Infection	NULL
,	NULL
in	NULL
Embury	NULL
SH	NULL
,	NULL
Hebbel	NULL
RP	NULL
,	NULL
Mohandas	NULL
N	NULL
,	NULL
Steinberg	NULL
MH	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Sickle	NULL
Cell	NULL
Disease	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Raven	NULL
,	NULL
1994	NULL
,	NULL
p	NULL
567	NULL
53	NULL
.	NULL

Hebbel	NULL
RP	NULL
:	NULL
Perspectives	NULL
series	NULL
:	NULL
cell	NULL
adhesion	NULL
in	NULL
vascular	NULL
biol-ogy	NULL
.	NULL

Adhesive	NULL
interactions	NULL
of	NULL
sickle	NULL
erythrocytes	NULL
with	NULL
endothelium	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
99:2561	NULL
,	NULL
1997	NULL
54	NULL
.	NULL

Lipowsky	NULL
HH	NULL
,	NULL
Sheikh	NULL
NU	NULL
,	NULL
Katz	NULL
DM	NULL
:	NULL
Intravital	NULL
microscopy	NULL
of	NULL
capillary	NULL
hemodynamics	NULL
in	NULL
sickle	NULL
cell	NULL
disease	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
80:117	NULL
,	NULL
1987	NULL
55	NULL
.	NULL

Setty	NULL
BN	NULL
,	NULL
Stuart	NULL
MJ	NULL
:	NULL
Vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
is	NULL
involved	NULL
in	NULL
mediating	NULL
hypoxia-induced	NULL
sickle	NULL
red	NULL
blood	NULL
cell	NULL
adherence	NULL
to	NULL
endothelium	NULL
:	NULL
Potential	NULL
role	NULL
in	NULL
sickle	NULL
cell	NULL
disease	NULL
.	NULL

Blood	NULL
88:2311	NULL
,	NULL
1996	NULL
56	NULL
.	NULL

Hofstra	NULL
TC	NULL
,	NULL
Kalra	NULL
VK	NULL
,	NULL
Meiselman	NULL
HJ	NULL
,	NULL
Coates	NULL
TD	NULL
:	NULL
Sickle	NULL
erythrocytes	NULL
adhere	NULL
to	NULL
polymorphonuclear	NULL
neutrophils	NULL
and	NULL
activate	NULL
the	NULL
neutrophil	NULL
respiratory	NULL
burst	NULL
.	NULL

Blood	NULL
87:4440	NULL
,	NULL
1996	NULL
57	NULL
.	NULL

Sowemimo-Coker	NULL
SO	NULL
,	NULL
Meiselman	NULL
HJ	NULL
,	NULL
Francis	NULL
RB	NULL
Jr	NULL
:	NULL
Increased	NULL
circulating	NULL
endothelial	NULL
cells	NULL
in	NULL
sickle	NULL
cell	NULL
crisis	NULL
.	NULL

Am	NULL
J	NULL
Hematol	NULL
31:263	NULL
,	NULL
1989	NULL
58	NULL
.	NULL

Hebbel	NULL
RP	NULL
:	NULL
Membrane-Associated	NULL
Iron	NULL
,	NULL
in	NULL
Embury	NULL
SH	NULL
,	NULL
Hebbel	NULL
RP	NULL
,	NULL
Mohandas	NULL
N	NULL
,	NULL
Steinberg	NULL
MH	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Sickle	NULL
Cell	NULL
Disease-Basic	NULL
Principles	NULL
and	NULL
Clinical	NULL
Practice	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Raven	NULL
,	NULL
1994	NULL
,	NULL
p	NULL
163	NULL
59	NULL
.	NULL

Mohazzab	NULL
KM	NULL
,	NULL
Kaminski	NULL
PM	NULL
,	NULL
Wolin	NULL
MS	NULL
:	NULL
NADH	NULL
oxidoreduc-tase	NULL
is	NULL
a	NULL
major	NULL
source	NULL
of	NULL
superoxide	NULL
anion	NULL
in	NULL
bovine	NULL
coronary	NULL
artery	NULL
endothelium	NULL
.	NULL

Am	NULL
J	NULL
Physiol	NULL
266	NULL
:	NULL
H2568	NULL
,	NULL
1994	NULL
60	NULL
.	NULL

Zimmerman	NULL
GA	NULL
,	NULL
Lorant	NULL
DE	NULL
,	NULL
Mcintyre	NULL
TM	NULL
,	NULL
Prescott	NULL
SM	NULL
:	NULL
Juxtactrine	NULL
intercellular	NULL
signaling	NULL
:	NULL
Another	NULL
way	NULL
to	NULL
do	NULL
it	NULL
.	NULL

Am	NULL
J	NULL
Respir	NULL
Cell	NULL
Mol	NULL
Biol	NULL
9:573	NULL
,	NULL
1993	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1998	NULL
92	NULL
:	NULL
3924-3935	NULL
Interaction	NULL
of	NULL
Sickle	NULL
Erythrocytes	NULL
With	NULL
Endothelial	NULL
Cells	NULL
in	NULL
the	NULL
Presence	NULL
of	NULL
Endothelial	NULL
Cell	NULL
Conditioned	NULL
Medium	NULL
Induces	NULL
Oxidant	NULL
Stress	NULL
Leading	NULL
to	NULL
Transendothelial	NULL
Migration	NULL
of	NULL
Monocytes	NULL
A	NULL
_	NULL
48	NULL
o	NULL
6	NULL
'	NULL
t	NULL
“	NULL
f.9	NULL
'	NULL
.	NULL
'	NULL

e	NULL
>	NULL
\	NULL
/	NULL
{	NULL
®	NULL
Chand	NULL
Sultana	NULL
,	NULL
Yamin	NULL
Shen	NULL
,	NULL
Vinod	NULL
Rattan	NULL
,	NULL
Cage	NULL
Johnson	NULL
and	NULL
Vijay	NULL
K.	NULL
Kalra	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/92/10/3924.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Red	NULL
Cells	NULL
(	NULL
1159	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

